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ABSTRACT
The actin cytoskeleton is implicated in numerous processes such as cellular division, 
migration, endocytosis/exocytosis, and more recently synaptic plasticity. Important players in 
controlling cytoskeletal rearrangements are the Cyclase Associated Proteins (CAPs) which are 
thought to link cell signalling to the dynamics of the actin cytoskeleton, via sequestration of monomeric 
actin subunits. CAPs are conserved throughout evolution and possess conserved functional 
domains. Previous studies have suggested a link between CAP proteins and vesicle trafficking and 
this study focussed on characterizing binding partners of human CAPs. Using a two hybrid screen 
of a human adult brain cDNA library, a novel human CAP interacting protein named Neuronal calcium 
binding protein 1 (Necabl) has been isolated. Necabl is a 351 amino acid protein containing a 
predicted calcium binding EF-hand and three coiled-coil domains. It is highly expressed in human 
brain, and similar to CAP2, displays high levels of expression within the hippocampus and cerebral 
cortex of rat brain. In vitro binding and in vivo immunoprecipitations demonstrate that CAP2 interacts 
with N ecab l Two-hybrid interaction assays performed with deletion mutants, in addition to 
site-directed mutagenesis of the coiled-coils of CAP2 (R10T, L11P) and Necabl (1218K, L221R), 
reveal that the central coiled-coil of Necabl interacts with the amino proximal coiled-coil of CAP2 (RLE 
motif). It is also demonstrated that Necabl can interact with the neuronal t-SNARE syntaxin 1a, 
suggesting a role in synaptic transmission. Furthermore, fractionation studies on rat brain reveal that 
Necabl and CAP2 are mainly cytosolic proteins, but also display some membrane localization. 
Immunolocalization studies in neuronal PC12 cells, demonstrate that CAP2 colocalizes with Necabl 
in neurites, but not with F-actin. In order to further understand the functional role for Necabl and 
CAP2, immunoprecipitations demonstrate that when CAP2 is bound to Necabl, no actin binding 
occurs, and that this inhibition is independent of Ca2+. Furthermore, actin polymerization assays reveal 
for the first time that CAP2 is a potent inhibitor of F-actin formation. Necabl does not demonstrate any 
concurrent function with CAP2 in these assays, but does inhibit filament formation itself to some 
degree. To study potential mechanisms of CAP2 regulation, in vivo labelling studies were performed. 
Results demonstrated that CAP2 is phosphorylated in the C-terminus. Analysis of the C-terminus of
iii
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CAP2 reveals a domain that is conserved within all CAPs, in which two serine residues are predicted 
to be potential phosphorylation sites. Thus, results suggest that human CAP2 functions to regulate 
the formation of actin filaments where it likely responds to cell signalling events. Furthermore, a 
neuronal role is proposed where CAP2 may function during events of synaptic transmission and 
plasticity in conjunction with Necabl.
iv
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CHAPTER ONE 
Introduction
Actin is the most abundant protein in eukaryotic cells, compromising 5-10% of a cells total 
protein. In the monomer form, globular actin (G-actin) is a protein of 42 kDa and is conserved from 
yeast to humans with 90% amino acid homology. Due to actin’s intrinsic ATPase activity, at 
physiological conditions, G-actin can spontaneously self-associate and polymerize into filamentous 
actin (F-actin), and results in the hydrolysis of the bound ATP molecule. Actin filaments are polar, in 
that they have two distinct ends; a fast growing barbed (+) end in which actin polymerization is 
favoured, and a slow growing pointed end (-) where the removal of G-actin is favoured (reviewed in 
Carlier and Pantaloni, 1997). At steady state, the addition of monomers on the barbed end equals the 
release of monomers on the pointed end. The critical concentration for actin is 0.1 uM. Thus, if the 
concentration of G-actin rises above this, actin polymerizes until the critical concentration is reached. 
However, the concentration of actin in the unpolymerized form is found well above this level in a wide 
array of organisms (Pollard et al., 2000). This seeming contradiction and the mechanism of equilibrium 
between G and F-actin is regulated, can be explained by the presence and activity of a plethora of 
actin binding proteins found in all eukaryotic cells.
Actin binding proteins can be organized into different groups based on their function: filament 
severing proteins, such as gelsolin and brevin bind to the side of an F-actin filament, breaking it apart 
and causing a decrease in the viscosity of the cytoplasm; filament depolymerizing proteins, such as 
the Actin Depolymerization Factor (ADF) family of proteins and cofilin, can bind to side of filaments and 
break them into G-monomers; capping proteins, such as Cap Z, bind to the end of actin filaments thus, 
preventing filament elongation and promoting depolymerization; anchoring proteins, such as 
dystrophin and vinculin, tether the actin cytoskeleton to the plasma membrane; filament bundling 
proteins, such as actinin, which are capable of crosslinking actin filaments; and finally monomer 
sequestering proteins, such as the Cyclase Associated Proteins (CAPs) and profilin, which bind G- 
actin, thus preventing it from being polymerized. Furthermore, these proteins promote F-actin 
polymerization by delivering monomers to sites of actin turnover. The nature of certain actin binding
1
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proteins is oversimplified as some proteins have other actin binding properties beyond those which 
have been described. For example, cofilin is able to depolymerize F-actin and bind G-actin depending 
on pH (Bernstein et al., 2000; Maciver and Hussey, 2002). The CAPs have recently been shown to 
have other actin binding properties beyond G-actin sequestration, such as depolymerization on the 
pointed end, and the ability to facilitate the addition of actin monomers on the barbed end (Moriyama 
and Yahara, 2002). Numerous other actin binding proteins exist, some with specific tissue/organ 
expression suggesting a functional correlation with their expression pattern.
Actin filaments, monomers and their associated proteins are organized into a highly dynamic 
structure called the actin cytoskeleton, which is involved in a wide array of cellular functions. Some 
well studied roles for the cytoskeleton include maintaining cell structural integrity, cellular movements 
and locomotion, shape changes and cell division/cytokinesis (see references within Schmidt and Hall, 
1998). Locomotion and cellular movements are driven by the spread of pseudopods (also known as 
lamellipods), which are due to the extension of actin filaments on the barbed end (front of the 
lamellipod), and disassembly at the pointed end (rear of the lamellipod) by an array of actin binding 
proteins (reviewed in Carlier and Pantaloni, 1997). A role for the actin cytoskeleton is also realized 
in the processes of endocytosis/exocytosis (vesicle trafficking), and during synaptic plasticity, though 
the exact function during these processes is still unclear.
Cyclase Associated Proteins (CAPs)
The Cyclase Associated Proteins are actin monomer binding proteins that are thought to link 
cell signalling to morphological changes in the actin cytoskeleton (reviewed in Hubberstey and Mottillo, 
2002). CAP was first identified in yeast over ten years ago in two independent studies. Yeast CAP 
was identified through its ability to alleviate phenotypes associated with an activated RAS2 allele 
(Fedor-Chaiken et al., 1990). The second study identified CAP as a complex with adenylyl cyclase 
(Cyrlp), hence the name CAP (Field et al., 1990). Both studies, identified yeast CAP as a signalling 
molecule between RAS and its effector Cyrlp. Deletion of yeast cap not only revealed that Ras 
signalling was compromised, but cells also demonstrated four additional phenotypes: inability to grow
2
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on rich medium; perturbations in temperature responses; sensitivity to nitrogen starvation; and an 
altered cell morphology resulting in larger and rounder cells, thus possessing a perturbed actin 
cytoskeleton (Vojtek et al., 1991). Since these phenotypes are not associated with Ras signalling, 
yeast CAP was thought to link temperature and nutritional signalling responses to changes in the actin 
cytoskeleton. CAP’s ability to act through Ras signalling and bind adenylyl cyclase has not been 
demonstrated in higher eukaryotes, as only yeast S. cerevisiae and S. pombe have shown to be the 
case. The N- and C-termini of yeast CAP have different functions, thus mediating the different 
responses seen in cap- cells. The N-terminus was shown to be important for signalling through 
activated Ras (Gerst et al., 1991; Vojtek et al., 1991) and was further mapped to specific residues of 
N12, L13, and E28 (Shima et al., 1997). The C-terminus was demonstrated to be necessary for 
correct cell morphology and nutritional responses, and an actin binding domain was later identified in 
the terminal 27 amino acids (Gerst et al., 1991; Vojtek et al., 1991; Zelicof et al., 1996).
CAPs are conserved throughout evolution (Figure 1) as homologues exist in a wide-array of 
organisms such as pig, rat, mouse, human, D. discoideum, Candida albicans, Arabidopsis, cotton, 
Xenopus, and Drosophila, suggesting a fundamental function for CAPs in regulating actin dynamics 
(Bahn and Sundstrom, 2001; Barrero et al., 2002; Baum et al., 2000; Gieselmann and Mann, 1992; 
Gottwald et al., 1996; Kawai et al., 1998; KhosrowShahian et al., 2002; Vojtek and Cooper, 1993; Yu 
etal., 1994; Zelicof et al., 1993). Furthermore, mammals contain two homologues of yeast CAP, CAP1 
and CAP2, but this is likely to extend to other vertebrates, as a Xenopus CAP2 homologue has been 
recently cloned and characterized (unpublished results, KhosrowShahian, F., Mottillo, E., Hubberstey, 
A. V. and Crawford, M. J.).
All CAPs have conserved functional domains in addition to the previously described actin 
binding domain and the adenylyl cyclase binding domain (Hubberstey and Mottillo, 2002) (Figure 2). 
Though adenylyl cyclase binding does not exist beyond yeast, this domain is structurally conserved 
and reveals a heptad repeat region, otherwise known as a coiled-coil domain. Coiled-coils consist of 
two to five amphipathic alpha-helices that wind around one another, forming a supercoil, which acts
3
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Figure 1. CAP phylogenetic tree demonstrating the relationships between all CAPs. Amino acid 
sequences of all 14 CAPs were aligned to construct a phylogenetic tree using TreeView software. The 
values next to the branches indicate the % amino acid identities between different CAPs.
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Figure 2. General conserved structural domains of the Cyclase Associated Proteins (CAPs).
The N-terminus of all CAPs contain a highly conserved sequence of amino acids; alanine, arginine and 
glutamic acid in repeat, and has been denoted the RLE motif. This RLE motif makes up the larger 
coiled-coil of CAPs. In yeast adenylyl cyclase binding occurs here, and is also the site of the 
N-terminal dimerization domain of all CAPs. CAPs also contain a central poly-proline region (PRO), 
a second dimerization domain localized to the C-terminus (Di) and a C-terminal proximal G-actin 
binding domain (Act).
6
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as a protein folding motif important for mediating protein-protein interactions, such as oligomerization 
(Burkhard et al., 2001). Not surprisingly, one of the dimerization domains has been mapped in this 
vicinity, and a second dimerization domain exists within the C-terminus (Hubberstey et al., 1996). 
Therefore, CAPs are capable of forming multimeric complexes and have also been shown to form 
oligomers in the size range of 440 - 669 kDa (Moriyama and Yahara, 2002). Another functional 
domain is the central poly-proline region of CAP, which has been shown to bind SH3 domains of other 
proteins. This domain binds yeast actin binding protein 1 (Abplp) (Freeman et al., 1996).
CAPs have been observed to have a multitude of cellular functions in different systems. 
Firstly, CAPs are thought to play a role in cell elongation, as a cotton homologue of CAP was isolated 
and shown to be highly expressed during fibre elongation (Kawai et al., 1998). CAPs have also been 
tied to a role in cell elongation as a CAP homologue in Arabadopsis, AtCAPI, was recently cloned and 
characterized. Overexpression of AtCAPI reduced F-actin filament formation and generated 
phenotypes of reduced leaf and petiole size which was attributed to a decrease in cell size and 
number (Barrera et al., 2002). CAPs have also been shown to have a fundamental purpose in 
development. A Drosophila homologue of CAP (acu/capulet) was first isolated through its ability to 
induce changes in the morphogenetic furrow of the eye disc. Acu was shown to be required for cell 
shape changes during this differentiation process, via its ability to prevent actin polymerization. Acu 
was also demonstrated to have a role in controlling the steps that lead to neuronal differentiation within 
the eye disc (Benlali et al., 2000). Capulet was simultaneously isolated through a screen for genes 
required in oocyte polarity. A similar actin function for capulet was identified as its accumulation within 
the oocyte inhibited actin polymerization. Mutants for capulet had a disrupted oocyte polarity, as an 
improper distribution of mRNA was evident, and this polarity function of CAP was also evident within 
yeast (Baum et al., 2000). A further study on capulet identified it as a major player in the spatial control 
of the actin cytoskeleton. Capulet prevented the formation of actin filaments on the apical side of 
epithelial cells, and its effects were modulated through the Abl tyrosine kinase, though biochemical 
proof of this signalling pathway awaits (Baum and Perrimon, 2001). Further proof for the function of 
CAPs during development is evident in the Xenopus homologue, xCAP1. xCAP1 was shown to be
8
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developmental^ regulated as it is expressed as a maternal transcript and was subsequently 
upregulated prior to gastrulation and through to the neurula stages (KhosrowShahian et al., 2002).
An role for CAPs during vesicle trafficking and endocytosis/exocytosis has been apparent for 
some time. The first indication that CAPs may have a role in endocytosis was demonstrated in yeast 
by the ability of the homologue of the neuronal v-SNARE synaptobrevin, SNC1, to complement 
phenotypes associated with deletion of the C-terminus of yeast CAP. Specifically these phenotypes 
were nutritional and temperature responses, and abnormal cell size, while Ras responsiveness was 
not restored (Gerst et al., 1992). Yeast CAP (Srv2) was genetically implicated in the endocytic 
process through a screen for mutants deficient for endocytosis. A recessive negative form of yeast 
CAP that was unable to internalize pheromone was identified, as the cap- strain was not deficient for 
endocytosis. Also, End4/Sla2 was shown to have a function in endocytosis that is redundant with that 
of Srv2 and Abp1. An End4 mutant missing its coiled coil domain in both an Srv2 and Abp1 deletion 
background, was unable to internalize labeled pheromone (Wesp et al., 1997). This study suggests 
that a complex of proteins consisting of End4, Rvs167, Abp1 and CAP work in concert to mediate the 
endocytic function of actin. Yeast Abp1 and CAP have been biochemically linked (Freeman et al., 
1996), and a characterized role for Abp1 in endocytosis is apparent in both yeast and mammals 
(Kessels et al., 2001; Wesp et al., 1997). These results imply a possible role for mammalian CAPs 
in endocytosis, but whether or not this interaction is conserved in mammals, remains to be resolved. 
In characterizing the Dictyostelium homologue of CAP, Noegel et al. also discovered a role for CAP 
in endocytosis. Mutants deficient for CAP demonstrated no disruptions during phagocytosis, but had 
a substantially reduced fluid phase uptake (Noegel et al., 1999). More recently, a proteomic screen 
of proteins involved in cell polarity in S. cerevisiae, revealed that CAP can interact with other proteins 
players of endocytosis. Two-hybrid interaction screens revealed that yeast CAP can interact with 
Rvs167 (Lombardi and Riezman, 2001), a regulator of endocytosis and the actin cytoskeleton; and 
Sla1 p, implicated in coupling the endocytic machinery to the actin cytoskeleton (Warren et al., 2002). 
Therefore, it is apparent that CAPs in general have an implied function in vesicle trafficking. The 
studies that identified a role for the CAPs in vesicle trafficking are model systems for vertebrate cellular
9
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function, in addition, the highly conserved function of all CAP merits investigation of the role that 
mammalian CAPs may play.
Role of the Actin Cytoskeleton During Vesicle Trafficking 
Endocytosis
Endocytosis is the active process by which cells internalize material such as proteins and 
lipids from their extracellular surroundings (Figure 3). One of the more well studied endocytosis 
pathways is clathrin-mediated endocytosis, which is initiated by the recruitment of the protein clathrin 
from the cytoplasm to defined sites on the plasma membrane. Clathrin monomers (consisting of a light 
and heavy chain) then assemble into a lattice of hexagons and pentagons in the shape of cage-like 
structure termed a clathrin-coated pit (CCP), followed by cargo recruitment. Detachment of the 
developed clathrin coated vesicle occurs, followed by transport of the vesicle into the cytoplasm 
(McPherson, 2002; Robinson et al., 1996). An important player in the late stages of clathrin-coated 
vesicle (CCV) formation is the large GTPase dynamin which is actively recruited to coated pits. It is 
thought that in the unbound state dynamin is found in the clathrin lattice, and upon GTP binding, the 
dynamins form a ring around the invaginated plasma membrane. Upon GTP hydrolysis, dynamins 
create a force that mediates membrane fission and pinching off of the new vesicle (Altschuler et al., 
1998; Urrutia et al., 1997). Another important aspect of vesicle formation is the inclusion of targeting 
proteins within vesicles, termed SNARE (soluble /V-ethylmaleimide-sensitive fusion attachment protein 
receptor) proteins, named so on based their ability to bi nd SNAP, a major component of the membrane 
fusion apparatus (Sollneretal., 1993). SNAREs are thought to be necessary for membrane targeting 
and will be further addressed in the section dealing with exocytosis.
In yeast, endocytosis and the actin cytoskeleton have been linked through genetic studies. 
Mutations in genes required for receptor-mediated endocytosis also result in perturbations of the actin 
cytoskeleton (Geli and Riezman, 1998; Munn et al., 1995). Additionally, use of actin depolymerizing 
drugs in yeast disrupts the internalization steps of endocytosis (Munn, 2001). The role for the
10
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Figure 3. Endocytic and exocytic events w ithin the synapse. A synaptic bouton is illustrated, 
showing the endocytic (green) and exocytic (yellow) processes. Actin filaments are illustrated in red, 
where they function as a scaffold for vesicles at the reserve pool (1), and are though to function in 
tracking vesicles to the active zone (2) (Doussau and Augustine, 2000) where they dock with the 
plasma membrane. Prior to exocytosis, actin acts to inhibitthe fusion of vesicles (3), where its removal 
is thought to be required in order for fusion to occur (Doussau and Augustine, 2000). The vesicle 
fusion reaction is regulated by the SNARE proteins, but Ca2+is the actual trigger for fusion and the 
subsequent release of neurotransmitter (4) (Brunger, 2000). Fused vesicles are then endocytosed, 
in which the actin cytoskeleton is thought to play a facilitative role (5) in addition with receptor- 
mediated endocytosis (6) (Qualmann et al., 2000; Schafer, 2002). Vesicles are then pinched off, in 
which dynamin plays a major part (7) (Altschuler et al., 1998; Urrutia et al., 1997), and are targeted to 
endosomes for recycling (light blue; 8) or back to the golgi ( grey; 9). In addition, vesicles that have 
been endocytosed following exocytosis, can be targeted back to the reserve pool (10) (Shupliakov et 
al., 2002). Intracellular traffic also occurs between endosomes and golgi (11). Figure adapted from 
Lin and Scheller (2000).
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actin cytoskeleton during endocytosis in mammalian cells is not so clear; few genetic links exist, and 
the use of actin depolymerizing drugs disrupts endocytosis depending on the assay and cell type used 
(Geli and Riezman, 1998). More recently, the use of actin perturbing drugs has revealed thatthe actin 
cytoskeleton plays more of a facilitative role in receptor-mediated endocytosis (Figure 3), but does 
not inhibit the formation of coated vesicles in ail cases tested (Schafer, 2002).
One molecular link in mammals between the actin cytoskeleton and endocytosis involves the 
protein mammalian Abp1 (mAbpI). As mentioned earlier, in yeast Abp1 and CAP interact with each 
other in concert with other proteins to mediate the endocytic function of actin. mAbpI binds 
filamentous actin via its two actin binding domains consisting of an actin depolymerization factor - 
homology (ADF-H) domain and also a novel actin binding motif (Kessels et al., 2000). 
Immunocytochemical studies support mAbpl's F-actin binding properties, as it localizes to the cortical 
actin cytoskeleton, and furthermore can relocalize to areas of high actin turnover at the leading edges 
of migrating cells (Kessels etal., 2000). mAbpI has been linked to endocytosis via dynamin, as in vivo 
studies demonstrate a relevance for this interaction, and is dependent upon mAbpl's SH3 domain 
(Kessels et al., 2001). The function of mAbpI in receptor-mediated endocytosis was demonstrated 
by a decrease in the uptake of labeled transferrin upon overexpression of its SH3 domain. This 
decrease in uptake was abolished upon overexpression of dynamin, thus strengthening the relevance 
of the interaction, and mAbpI as a link between the actin cytoskeleton and endocytosis (Kessels et 
al., 2001). Another molecular link in mammalian systems involves the Huntington Interacting Protein 
1 (HIP1) and HIP-Related (HIP1R), mammalian orthologues of yeast Sla2p (McPherson, 2002). As 
mentioned, Sla2p and yeast CAP have been functionally associated, thus is another example of a 
protein that provides an intimate link between CAPs and endocytosis. Both HIP proteins are 
associated with clathrin coated vesicles and clathrin coated pits, and function to facilitate the assembly 
of clathrin structures (McPherson, 2002). The HIPs functionally link the cytoskeleton to clathrin coats 
by their ability to bind F-actin and coats simultaneously. The formation of this actin-clathrin complex 
through the HIPs, is thought to allow the recruitment and assembly of clathrin at the plasma 
membrane. Currently no evidence exists for an association between mammalian CAPs and the HIPs
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or mAbpI; thus, studies that search for novel mammalian CAP binding partners will be essential in 
further understanding their function.
The actin cytoskeleton could have numerous different functions during endocytosis, each one 
occurring at different stages of the endocytic process (Qualmann et al., 2000; Schafer, 2002). Firstly, 
the actin cytoskeleton may act as a scaffold for the numerous protein players involved in endocytosis 
and its rearrangement would elicit their function. A possible second role for the actin cytoskeleton is 
in the invagination of plasma membrane, wherein the actin cytoskeleton would facilitate or support this 
process. Thirdly, the cortical actin cytoskeleton may act as a barrier at the plasma membrane, thus 
in this case it would be inhibitory to the process and its removal would be a prerequisite for the 
invagination of vesicles. A fourth role for the cytoskeleton, is during the membrane fission which 
results in the liberation of vesicles from the plasma membrane. In this step, the polymerization of actin 
at the neck of the vesicle would provide the force needed to detach it. A final role for the actin 
cytoskeleton exists in the movement of endocytic vesicles through the cytoplasm, wherein the 
polymerization of actin results in the formation of a comet tail, thus providing the force necessary for 
this movement. The propulsion properties of actin polymerization is clearly evident through the study 
of the pathogen Listeria monocytogenes which uses the cytoskeleton to propel itself through the 
cytoplasm (Portnoy et al., 2002). Though these numerous associations for the actin cytoskeleton 
during the different steps of endocytosis may seem convoluted, this can be attributed to the 
specialized roles that actin may play in different cell areas or types.
Exocytosis
Exocytosis is the term used to describe the fusion of a secretory vesicle with the plasma 
membrane and the subsequent release of its contents into the extracellular area (Figure 3). This 
process is either constitutive, or is highly regulated, were the secretion of cellular messengers such 
as neurotransmitters, cytokines, and hormones occurs only in response to extracellular signals. The 
most widely studied form of regulated exocytosis is calcium mediated neurotransmitter release, which 
occurs in synapses, and is the manner in which the nervous systems conducts cell to cell
14
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communications. The synaptic vesicle cycle first occurs with the synthesis of lipids and membrane 
proteins on the endoplasmic reticulum (ER) and their subsequent modification at the golgi apparatus. 
Mature synaptic vesicles are then filled with neurotransmitter at the nerve terminal and are targeted 
to the presynaptic area where regulated exocytosis occurs, otherwise called the active zone. Once 
near the active zone, vesicles can become either part of the reserve pool which is bound to 
cytoskeletal elements, or can become docked to the plasma membrane where they become part of 
the readily releasable pool (Figure 3) (Lin and Scheller, 2000). The subsequent steps all occur within 
the presynaptic terminal (Sudhof, 1995). Firstly, docking involves contact between the vesicle and 
plasma membrane, and is followed by a rate-limiting priming step that makes the vesicles competent 
to Ca2+ mediated exocytosis. Once vesicles are primed, they can be stimulated to fuse by the Ca2+ 
spike that occurs during an action potential. Once the synaptic vesicles have emptied their contents, 
they are internalized through a clathrin-mediated endocytic process. The CCV then shed their coat 
and are recycled by endosome fusion (Figure 3). New synaptic vesicles can now form from the 
budding of endosomes, and the process repeats itself.
The essential components for vesicle fusion, which are conserved from yeast to humans, can 
be grouped into three classes of protein (Jahn and Sudhof, 1999). The first class consists of the 
membrane bound SNAREs which can be further divided into two classes consisting of v-SNAREs 
(within transport vesicles) and t-SNAREs (localized to the target membrane for the vesicle) (Sollner 
et al., 1993). The second class of proteins consist of Muncl 8 homologues which bind to t-SNAREs 
and regulate their ability to bind v-SNAREs. The third class is made up of the Rab proteins which are 
small GTPases that regulate vesicular traffic through their ability to bind the SNAREs and Muncl 8 
homologues.
The SNARE hypothesis is an idea formulated to describe the fusion of vesicles with the 
plasma membrane through the cycling of assembly/disassembly of SNARE complexes. Though the 
initial hypothesis included the idea that the specificity of v-SNARE/t-SNARE interactions would 
modulate the specificity of membrane trafficking and targeting (Sollner et al., 1993), to date this has 
not been proven. The most frequently studied SNAREs are those involved in synaptic vesicle
15
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exocytosis and they represent the minimal machinery needed for fusion to occur. They consist of the 
t-SNAREs syntaxin 1a and SNAP-25 (membrane bound due to its palmitoylation), and the v-SNARE 
synaptobrevin (VAMP), wherein syntaxin 1 a and synaptobrevin contain C-terminal transmembrane 
domains. The neuronal SNAREs share homology within a region termed the SNARE motif which 
consists of a heptad repeat or coiled-coil domain. Through these SNARE motifs, the proteins can form 
a highly stable tetramer termed the SNARE complex, wherein syntaxin 1 a and synaptobrevin 
contribute one SNARE motif and SNAP-25 contributes two (Jahn and Sudhof, 1999). The current 
SNARE hypothesis (Brunger, 2000) initiates prior to docking, with syntaxin bound to its negative 
regulator nSed, and synaptobrevin likely bound to synaptophysin. Interestingly, as touched upon in 
the CAP discussion, the yeast homologue of synaptobrevin, SNC1, is able to complement certain cap- 
phenotypes. During docking, the syntaxin-nSed and synaptobrevin-synaptophysin interactions are 
broken, and synaptobrevin is then able to bind syntaxin and SNAP-25. In the priming step, the 
SNARE complex becomes competent to respond to an increase in intracellular Ca2+, likely through a 
calcium sensor protein such as synaptotagmin. During vesicle recycling SNAP (soluble NSF- 
attachment protein - not to be confused with SNAP-25) and the ATPase NSF, bind the SNARE 
complex and dissociate it upon ATP hydrolysis.
The role of the actin cytoskeleton in exocytosis/neurotransmitter release is not as well studied 
as that of endocytosis and fewer molecular links exist. As is the case with endocytosis, different roles 
for the actin cytoskeleton have been postulated depending on the cell and assay type used. In bovine 
chromaffin cells (of endocrine type) the role of the actin cytoskeleton has been clearly established 
during the secretory process (Trifaro et al., 2000). In these endocrine cells, a ring of filamentous actin 
exists beneath the plasma membrane acting as a barrier to release, thus trapping secretory granules 
and preventing their fusion with the plasma membrane. Upon stimulation the cortical cytoskeleton 
becomes depolymerized, and this facilitates the docking and fusion of vesicles (Doussau and 
Augustine, 2000; Trifaro et al., 2000). Additionally, actin filaments are highly concentrated in 
presynaptic terminals (Morales et al., 2000) and different roles have been postulated for the 
cytoskeleton during presynaptic function. Two pools of neurotransmitter vesicles exist within the
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synaptic terminal; a readily releasable pool (RRP) at the active zone which is primed for fusion, and 
a reserve pool, situated above the RRP (Lin and Scheller, 2000). A network of actin filaments along 
with cytoskeletal proteins exists at the reserve pool and its role is to act as a structure that maintains 
these vesicles (Figure 3) (Doussau and Augustine, 2000; Lin and Scheller, 2000). During steady 
neurotransmitter release a role for the actin cytoskeleton has been proposed in trafficking vesicles 
from the reserve pool to the RRP. Likewise, actin may serve as a track for vesicles to move between 
the two pools, or another idea is that depolymerization of actin filaments results in the release of 
reserve vesicles (reviewed in Doussau and Augustine, 2000).
Interestingly, recent studies suggest an inhibitory role for the actin cytoskeleton in 
neurotransmitter release (Figure 3). Ohnishi et al. (2001) demonstrated that the use of actin 
depolymerizing drugs facilitated the release of Ca2+ dependent neurotransmitter in the rat neuronal cell 
line PC12 and cerebrellar granule cells. Morales et al. used biochemical and electrophysiological 
studies to elucidate the step at which the inhibitory role occurred. Miniatures excitatory postsynaptic 
currents (mEPSCs), which represent the fusion of a single synaptic vesicle, were used to measure 
neurotransmitter release in primary hippocampal neurons. The use of the F-actin depolymerizing drug 
latrunculin A (Lat A), led to an enhancement of neurotransmitter release independent of Ca2+, while 
cytochalasin D did not (Morales et al., 2000). The authors propose that the actin cytoskeleton within 
the active zone acts as a structural component, or possibly a scaffold prior to the last stage of vesicle 
priming, and thus would need to by reorganized prior to the transition to the final stage.
One molecular link between the reserve pool of vesicles and the actin cytoskeleton is the 
synapsin family of proteins. These proteins demonstrate different actin binding properties, such as the 
ability to bind actin monomers and nucleate them, thus facilitating F-actin formation, and the ability to 
bind F-actin filaments and bundle them (reviewed in Doussau and Augustine, 2000). Functional 
studies such as the microinjection of synapsin antibodies or knockout mice of synapsin, disrupts the 
reserve pool, thereby inhibiting the release of subsequent neurotransmitter and demonstrate 
synapsins as regulators of the reserve pool (Doussau and Augustine, 2000).
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Role of the Actin Cytoskeleton During Neuronal Plasticity
During brain development synaptic wiring occurs, wherein neurons extend axons and 
dendrites, thus making new synaptic connections. This active process is called neurite outgrowth and 
involves the actin cytoskeleton (Luo, 2002). The leading edge of a neurite contains an actin rich 
structure called a growth cone, which is composed of filopodia, and meshworks of actin termed 
lamellipodia situated between filopodia. The finger shaped filopodia are composed of F-actin bundles 
and are constantly extending due to the addition of actin monomers at the leading edge. At the trailing 
edge F-actin filaments are broken down and allows the growth cone to move forward. Simultaneously, 
at the veil shaped lamellipods, a net F-actin flow away from the leading edge causes filopodia and 
lamellipodia to retract. The lamelipodia are then built forward where they meets the tip of filopodia. 
New filopodia then extend from the leading edge and the process repeats itself. Thus, the net rate of 
growth is controlled by independently adjusting the rates of actin polymerization and F-actin flow (Luo, 
2002). The regulation of growth cone formation is also an important feature of axon guidance. Well 
after development, morphological changes in neurons continue, such as growth and pruning of 
neuronal connections, the addition or removal of synapses, and changes in synaptic size and shape, 
all of which are thoughtto be associated with learning and memory formation. More importantly, these 
changes are dependent on the dynamics of the actin cytoskeleton (Luo, 2002).
One of the fundamental questions in neuroscience is how the nervous system modifies itself 
to create memories and facilitate learning. Synaptic plasticity is the term used to describe this 
apparent ability of the nervous system to change the strength of synaptic connections (Yuste and 
Bonhoeffer, 2001). One of the more widely studied forms of plasticity is Long Term Potentiation (LTP) 
which is a prolonged enhancement of synaptic strength, and is argued to be the mechanism behind 
learning and memory formation (Malenka and Nicoll, 1999). Specifically, LTP occurs within the 
hippocampus during strong periods of stimulation, when a synaptic input is activated at the same time 
that depolarization is occurring in the postsynaptic cell (Malenka and Nicoll, 1999). The site of LTP 
has been pinpointed to areas where the majority of excitatory synaptic inputs occur: between 
presynaptic terminal of axons and the postsynaptic terminals of dendrites called dendritic spines
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(Yuste et al., 2000). Dendritic spines function to integrate the multiple input signals that are received 
from presynaptic terminals of innervating axons. Spines are thoughtto act as separate structures that 
compartmentalize and restrict calcium and proteins involved in synaptic function. Consequently, 
signals received on one spine do not spread to another on the same dendrite allowing for each 
synaptic contact within a neuron to be adjusted separately (Yuste et al., 2000). This idea is thought 
to be the basis for the relationship between LTP function and learning and memory formation.
Research in the lastten years has demonstrated thatthe chemical and structural modifications 
that occur within dendritic spines are fundamental mechanisms behind LTP, thus learning and memory 
formation (reviewed in Yuste and Bonhoeffer, 2001). Interestingly, actin is highly enriched within 
dendritic spines (Smart and Halpain, 2000) and recent research has focussed on studying if the 
structural modifications within them are due to the actin cytoskeleton. A role for the actin cytoskeleton 
during LTP was deduced through the use of actin depolymerizing drugs on hippocampal mouse slices, 
where maintenance of LTP within slices was impaired. The effects of Cytochalasin B were reversible, 
as washing returned the slices to a state where LTP could occur. Actin depolymerizing drugs act on 
dynamic filaments, and the fact that removal of Cytochalasin B returned actin to a dynamic state, 
suggests that actin dynamics are essential to synaptic plasticity (Krucker et al., 2000). In another 
study the use of the depolymerization drug Lat A in cultured hippocampal neurons was used to study 
the role of actin in synapse stability and formation. The authors demonstrated that F-actin is pertinent 
to the development and maintenance of synapses, as young hippocampal neurons treated with the 
drug demonstrated a complete loss of synapses. The use of Lat A had no effect on mature neurons, 
suggesting that a stable F-actin cytoskeleton is critical to the maintenance of mature synapses (Zhang 
and Benson, 2001). An elegant study by Colicos et al. allowed a real-time view of the pre- and 
postsynaptic changes that occur during LTP. They utilized the property thatthe electrical conductivity 
of silicon is enhanced when exposed to light. By layering hippocampal neurons on a silicon wafer and 
illuminating a single neuron, this resulted in the activation of that single neuron. The advantages of 
this technique is that it is noninvasive, and the effects on a single neuron can be studied. By using the 
fluorescent reporter gene GFP and its derivatives, the authors revealed that the elicitation of LTP
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resulted in the reorganization of actin, as presynaptic actin advanced toward the synapse, and 
postsynaptic actin moved away from the stimulated synaptic terminal. Furthermore, these actin 
dependent changes during LTP result in what seemed to be the formation of new active pre- and 
postsynaptic connections (Colicos et al., 2001). Further studies are needed to discern if these actin- 
mediated synaptic changes result in synaptic plasticity.
A study by Meng et al. used a LIM kinase 1 (LIMK-1) knockout mouse to study its regulatory 
role in neuronal function. Abnormal expression of LIMK-1 along with other proteins results in the 
human developmental disorder Williams syndrome, which is characterized by mental retardation and 
deficits in visuospatial cognition. LIMK is an important regulator of actin dynamics via its ability to 
inactivate the actin binding protein cofilin. Cofilin is an important player in binding G-actin and severing 
F-actin, thereby resulting in the treadmilling of filaments (reviewed in Bamburg, 1999; Bamburg et al., 
1999). Levels of activated cofilin were substantially higher in the brain of LIMK-1 knockout mice, and 
the distribution of actin filaments in dendritic spines and branches was significantly altered, likely due 
to increased activity of cofilin. The knockout mice also manifested abnormalities in dendritic spine 
morphology and in synaptic function, and more interestingly demonstrated an enhancement in LTP. 
The mice also showed alterations in fear responses and spatial learning suggesting a role for LIMK-1 
in behaviour. These results suggest that LIMK-1 is involved in spine morphogenesis and synaptic 
plasticity through its regulation of the actin cytoskeleton (Meng et al., 2002). Recently, the human 
CAPs have been biochemically linked to cofilin, likely aiding in the turnover of actin filaments 
(Moriyama and Yahara, 2002), and suggestive in that they too may play a role in neuronal plasticity.
Signalling to the Actin Cytoskeleton
An important aspect of actin is the signalling cascades that occur following the binding of a 
morphogen onto the cell surface, resulting in morphological changes of the cytoskeleton. Signalling 
to the actin cytoskeleton in mammalian cells is controlled by the Rho family of GTPases which include 
Rho, Rac and Cdc42. GTPases are small proteins that act as molecular switches and are involved 
in a wide array of cellular functions (reviewed in Matozaki et al., 2000). When in the GTP-bound state
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GTPases are active, while when bound to GDP they are inactive. When extracellular signals are 
received, a GEF (Guanine nucleotide Exchange Factor) facilitates the exchange of GDP for GTP, 
activating the GTPase, and causing a conformational change. The active GTPase can now bind to 
downstream effectors and activate them, hence eliciting a signal transduction cascade. Conversely, 
GAPs (GTPase Activating Proteins) are negative regulators as they hydrolyse bound GTP to GDP, 
therefore inactivating the GTPase and the signalling cascade. Studies from fibroblasts have revealed 
that each member of the Rho family of GTPases actin response to different stimuli and control distinct 
morphological changes, but also act upon each other through a hierarchy of Cdc42 -  Ras -  Rho 
(Hall, 1998; Schmidt and Hall, 1998). Rho can illicit the formation of actin stress fibres and focal 
adhesions, acting in response to fetal calf serum and lysophosphatidic acid. Rac induces lamellipodia 
formation and membrane ruffles, and acts in response to different growth factors. Cdc42 is responsive 
to bradykinin and controls the formation of filopodia.
Though downstream effectors of the Rho family have been characterized, the full sequence 
of each cascade have yet to be determined. One fairly well characterized cascade is that of the Rho 
GTPase (Matozaki et al., 2000). ROCK is a serine/threonine kinase that is a downstream effector of 
Rho since it is stimulated by active Rho-GTP. Active ROCK can phosphorylate numerous targets such 
as the myosin light chain phosphatase, thereby inhibiting it, and leading to an induction of smooth 
muscle contraction. ROCK also acts on another pathway consisting of LIMK, wherein LIMK is 
phosphorylated/activated, and subsequently acts to phosphorylate and inactivate cofilin. Another 
effector of Rho is mDia which acts to bind profilin and control actin polymerization. Cdc42 controls the 
de novo polymerization of actin filaments through its downstream effector N-WASP (Luo, 2002). 
Active Cdc42 along with the lipid messenger PIP2, can bind to N-WASP and abolish its auto-inhibitory 
conformation. Active N-WASP can bind to the ARP2/3 complex and stimulate the formation of new 
barbed ends via the nucleation of actin monomers (reviewed in Welch and Mullins, 2002). 
Additionally, Cdc42 can activate the serine/threonine kinase effector PAK, which phosphorylates LIMK, 
leading to its activation. Interestingly, the Rac GTPases also act through PAK. Rac can also activate 
the ARP2/3 complex, but through a different pathway. Active Rac turns on the effector IRSp53
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activating SCAR/WAVE, SCAR/WAVE then stimulates ARP2/3 to perform its actin nucleation tasks. 
Thus, it is apparent that there is significant crosstalk between the Rho family of GTPases.
Members of the Rho family have also been shown to be activators/regulators of numerous 
actin-dependent cellular processes. The Arf and Rab family of GTPases control vesicle trafficking, 
specifically the budding and targeting of vesicles, respectively (Chavrier and Goud, 1999). Intriguingly, 
Rho family members are also implicated in endocytic traffic (Ellis and Mellor, 2000). Firstly, Rac and 
Rho function in clathrin-mediated endocytosis, as activated forms block the internalization of 
transferrin. This idea agrees with the recent implication in endocytosis for the F-actin binding protein 
HIP. Cdc42 and Rac mediate the formation of membrane protrusions that occur during phagocytosis 
such as the engulfment of bacteria. Rho is also implicated in phagocytosis, specifically during type 
II, wherein the particle to be phagocytosed enters into actin-lined invaginations in the plasma 
membrane (Ellis and Mellor, 2000). Additionally, the Rho GTPases RhoD and B are involved in 
endosomal sorting, while Cdc42 regulates endocytic and secretory pathways at the basolateral 
membrane in polarized cells. The Rho family has also been implicated in Ca2+ mediated 
neurotransmitter release. Doussau et al. (2000) revealed that Rac1 fractionates to synaptic vesicles 
and used activators/inhibitors to elucidate that Rac1 regulates a late stage in neurotransmitter release 
(Doussau et al., 2000). The step of R ad function was further demonstrated to occur after vesicle 
docking and during fusion competence (Humeau et al., 2002). Rho, Rac and Cdc42 also function in 
neurite outgrowth, mostly acting through different effectors. Rac and Cdc42 act to promote neurite 
outgrowth (mainly through PAK), while Rho acts through its effector ROCK to promote growth cone 
collapse (Nikolic, 2002). A neuronal function closely related to growth cone formation that the Rho 
family is implicated in, is axon guidance. Similarly, axon attraction is mediated through Cdc42 and 
Rac, while Rho acts in an antagonistic manner (Patel and Van Vactor, 2002). Rac and Rho are also 
involved in the maintenance of dendritic spines and branches, wherein Rac controls the maintenance 
of spine density, and Rho through its effector ROCK is involved in inhibiting the formation of dendritic 
branches (Nakayama et al., 2000). This study suggests thatthe Rho GTPases may also have a role 
in signalling during synaptic plasticity.
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Thesis Objectives
The major objective of the thesis was to further characterize the human Cyclase Associated 
Proteins CAP1 and CAP2. In particular, the objective was to identify new binding partners for hCAPs 
that may play a role in vesicle trafficking/neuronal function. In order to fulfill this aim, major 
experiments were performed that addressed four specific questions/objectives:
1. Identify new binding partners for hCAPs.
2. Characterize the interaction between hNecabl and CAP2.
3. Determine the subcellular localization of CAP2 and Necabl.
4. What is the functional purpose of the Necab1-CAP2 interaction and how is CAP2
regulated?
A yeast two-hybrid screen of a human adult brain cDNA library was performed using hCAP2 
as the bait protein. A novel protein with unknown function named Synaptotagmin Interacting Protein 
1 (STIP1) was isolated that interacted with both hCAPs. A function in synaptic vesicle trafficking was 
suggested for STIP1 since it contains a predicted calcium binding motif, and since synaptotagmins are 
thought to be calcium sensors for calcium mediated exocytosis (Augustine, 2001). However, the 
putative interaction with Synaptotagmin 1 was shown to be physiologically insignificant, and so the 
protein has been subsequently re-named Neuronal Calcium Binding Protein 1 (Necabl) (Sugitaetal., 
2002; Sugita and Sudhof, 2000). Thus, Necabl and the interaction was further characterized, as it 
implied a role for the hCAPs in vesicle trafficking (Chapter Two). Hereafter, this novel hCAP 
interacting protein will be referred to as Necabl in this thesis. Necabl is a 351 amino acid protein, 
containing a predicted single EF-hand calcium binding domain, and three repetitive coiled-coil 
domains. It is highly and preferentially expressed in human brain, with lower levels in kidney, trachea 
and lung. Further examination of expression within rat brain reveal that rat Necabl and CAP2 have 
a similar distribution. In vitro binding studies demonstrate that both CAP1 and CAP2 interact with 
Necabl. Surprisingly, immu noprecipitation analysis reveals that only CAP2 can bind Necabl in vivo. 
Yeast two-hybrid assays performed with deletion mutants and site directed mutagenesis reveal that 
the coiled-coil domains of both proteins are critical for CAP-Necab1 binding. The central coiled-coil
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of Necabl interacts with the amino proximal coiled-coil of CAP2 (termed the RLE motif). In mammalian 
cells, site-directed mutagenesis of the amino terminal coiled-coil of CAP2 (R10T, L11P) along with 
immunoprecipitation analysis has revealed that CAP2 (R1OT, L11P) does not interact with Necabl in 
vivo. Furthermore, it is shown that Necabl is a protein capable of dimerization. A closer inspection 
of Necabl reveals that it has a potential SNARE motif. It is also demonstrated that the neuronal t- 
SNARE syntaxin 1a interacts with Necabl through its SNARE motif.
Fractionation studies were performed in order to identify the subcellular localization of CAP2 
and Necabl (Chapter Three). These studies reveal that endogenous Necabl and CAP2 are mostly 
soluble cytosolic proteins, thatshow some localization to other compartments. The potential functional 
significance of the Necabl - CAP2 interaction was also studied (Chapter Four). This was 
accomplished through functional immunoprecipitations involving Necabl - CAP2 - actin complexes 
which demonstrated that CAP2 cannot bind actin when bound to Necabl. Actin polymerization assays 
demonstrate that CAP2 is a potent inhibitor of F-actin formation; but, Necabl has no effect on this 
function. Necabl itself may have an effect on polymerization, although a direct interaction between 
Necabl and actin was not demonstrated. In order to determine if CAP2 was involved in a cell 
signalling cascade, and to understand how it is regulated, we performed in vivo phosphorylation 
assays which revealed that CAP2 is highly phosphorylated in the C-terminus. The significance of 
these functional assays, with relation to the interactions described, and future experiments, will be 
discussed in Chapter Five.
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CHAPTER TWO 
Characterization of Necabl: a Novel CAP Binding Partner
Introduction
Protein interactions are the basis for all cellular processes that occur within a cell, and can be 
illustrated by the multitude of actin binding proteins which act hand in hand to rearrange the actin 
cytoskeleton. For example, yeast CAP is thought to function in concert with other proteins to mediate 
the function of the actin cytoskeleton during endocytosis (Wesp et al., 1997), and also during cell 
polarity development (Drees et al., 2001). Thus, teasing apart these protein complexes will be 
essential to assembling the puzzle of how actin functions during cellular processes. An additional 
example of the importance that protein interactions play in cellular processes is exemplified in the 
SNARE proteins, which mediate the release of neurotransmitter (Sudhof, 1995).
Another important aspect of neuronal function is Ca2+ signalling, since it plays a principal 
regulatory role. An increase in intracellular Ca2+ is the signal for the release of neurotransmitter 
between neurons of the brain. This signal is regulated by the C2 class of calcium binding proteins such 
as synaptotagmins; likely the calcium sensors for vesicle fusion (Augustine, 2001; Sudhof, 2002). 
Usually the binding of Ca2+ elicits a conformational change in the protein, allowing other proteins to 
interact with it. The second class of calcium binding proteins is the EF-hand motif family which consist 
of helix-loop-helix motifs, wherein the loop can co-ordinate a calcium ion. Usually calcium binding 
proteins of the EF-hand family contain an even pair of motifs that allow the proper co-ordination of the 
calcium ion. EF-hand proteins that contain only one motif demonstrate the ability to form homodimers 
in order to bind the calcium ion (Lewit-Bentley and Rety, 2000).
An aspect of neuronal function that has been ignored up until recently, is the role that actin 
may play in not only neurotransmitter release, but also synaptic plasticity. Further understanding the 
protein players involved in the reorganization of the actin cytoskeleton, and their putative binding 
partners within the brain, will allow a role for actin dynamics in neuronal function to be elucidated.
In this chapter, the isolation and characterization of a novel neuronal binding partner of the 
human CAPs named Neuronal Calcium Binding Protein 1 (Necabl) is described. We demonstrate
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that Necabl is highly and preferentially expressed in the brain. Further examination within the brain 
reveals that Necabl has an expression pattern similar to that of CAP2. Through the use of in vitro and 
in vivo binding assays, Necabl is shown to be a legitimate binding partner of CAP2. Further two- 
hybrid mapping using deletion mutants and immunoprecipitation analysis, along with site-directed 
mutagenesis on the CAP2 coiled-coil, demonstrate thatthe Necabl - CAP2 interaction occurs through 
coiled-coil domains. It is also shown that Necabl is a protein that can self-associate, likely to form 
dimers in a calcium-independent manner. Analysis and alignment of NecabTs central coiled-coil, 
reveals that it has homology with neuronal SNAREs. Binding studies demonstrate that Necabl can 
also directly interact with thet-SNARE syntaxin 1 a, and this interaction is mediated through syntaxin’s 
Q-SNARE motif. The justification for Necabl's interactions and its similar brain expression pattern with 
CAP2 suggests an important neuronal role for Necabl. Furthermore, it suggests that Necabl may be 
a modulator of CAP2 function within the brain.
Materials and Methods
Yeast Two-Hybrid Library Screen
Full-length human CAP2 was cloned into the yeast two-hybrid expression vector pBTM116 that 
contains the LexA coding sequence under the control of the yeast ADH1 promoter, and also the TRP1 
gene for selection, to create pLEX-CAP2. This in frame fusion with the LexA DNA binding domain was 
used as a bait to screen a human adult brain cDNA library (cloned into the activation domain plasmid 
pGADIO, Clontech). Briefly, the yeast L40 strain was first transformed with pLEX-hCAP2 and 
subsequently transformed with the brain two-hybrid cDNA library using lithium acetate method. 
Approximately 1*106 yeast transformants were screened for their ability to grow in the absence of 
histidine. Of these histidine prototroph transformants, ten yeast colonies were obtained and analyzed 
for their ability to turn blue in the presence of the colourimetric substrate 5-bromo-4-chloro-3-indolyl 
(3-D-galactopyranoside (X-gal). Often positive interacting clones, clone #5 (GAD10#5) demonstrated 
a positive interaction with both hCAP1 and hCAP2, and no ability to activate transcription by itself
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(transactivation). In orderto isolate library plasmid, yeast transformants were plated onto media which 
contained tryptophan that cured the bait plasmid (pLEX-CAP2). The loss of bait plasmid was 
confirmed by performing a P-gal assay on the cured yeast colonies. Library plasmids from cured 
transformants were subsequently isolated through membrane disruption of yeast with glass beads. 
Purified DNA plasmid was then subsequently electroporated into the E. coli strain DH10B. Clones 
were sequenced using dye-deoxy terminator reactions using either an ABI sequencing system (York 
University) or a Visible Genetic Long Read tower system using a Thermo Sequenase Cy 5.5 
Terminator Cycle Sequencing Kit (Amersham Pharmacia Biotech). Subsequent BLASTX search of 
clone GAD10#5 showed it had high homology to a partial human and full-length rat GenBank 
sequences named Neuronal Calcium Binding Protein 1 (Necabl) (GenBank A F 193756, A F 193755, 
Sugita and Sudhof, 2001).
cDNA Cloning o f Full-length Necab 1
GAD10#5 from the two-hybrid library screen encoded a clone of Necabl missing the 5' end. In order 
to clone full length Necabl, we performed a BLASTN search of the Human Genome Project database. 
Upon analysis of the chromosomal sequence it was determined that 12 base pairs were missing from 
the 5' end. This analysis, along with the full length sequence of rat Necabl (GenBank AF 193755), 
allowed us to PCR full length Necabl from the human brain cDNA library using the synthesized 
forward (#97) and reverse (#99) primers containing Xho1 sites (see Appendix A). The PCR product 
was gel purified to remove any contaminating library plasmid, and was subsequently subcloned into 
the Xho1 site of pBlueSript/SK IP (Stratagene) to create pBS-Necab1. This clone was subsequently 
used to clone into other vectors.
Molecular Cloning
A Full-length Necabl fragment with Xho1 sites (from pBS-Necab1) was used to clone into the Sail site 
of the His-Tag (pET-33b(+)), HA-tag (pCI-HA), and MYC-tag (pCI-MYC) vectors and the Xho1 site of 
GST vector (pGEX-KG) to create in frame fusion proteins. Polymerase chain reaction (PCR) was used
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to generate VP16 fusions of full length hNecabl and the appropriate deletion mutants using the 
primers listed in Appendix A. Primers were designed in such a way that both carboxyl and amino 
terminal deletion mutants had three variations of coiled-coil organization (See Figure 9 for schematic 
diagrams), and were used as follows: full-length VP16-Necab1 primers #125 and 130; Necab1-N284 
primers #125 and 127; Necab1-N250 primers #125 and 128; Necab1-N200 primers #125 and 129; 
Necab1-C156 primers #136 and 130; and Necab1-C100 primers #138 and 130. The LEX-Necab1 
fusion was made by PCR of Necabl using primers #137 and 99, and cloned into the Xho1 site of 
pBTM116. PCR was used to amplify CAP2 from pCI-HA-CAP2 in a 100 |jl reaction using Vent DNA 
polymerase (New England BioLabs) and forward (#31) and reverse (#32) primers designated in 
Appendix A. The PCR product was digested with EcoR1 and Xho1, and subsequently cloned into 
yeast two-hybrid expression vector pBTM116 (digested with EcoR1/Sal1) to create an in frame fusion 
between CAP2 and LEX. Cloning of GST-CAP2 and GST-CAP2-N304 fusion proteins was performed 
by PCR of fragments of full length CAP2 (primer #123 and #32) and the N-terminal 912 nucleotides 
(primer #123 and #109), respectively. This created 3' EcoR1 sites and 5' Xho1 sites that were used 
to clone into the pGEX-KG that was double digested with EcoR1/Xho1.
For cloning of the CAP2 coiled-coil mutant (CAP2tpe) site directed mutagenesis was 
performed in a one step PCR using the forward primer 5'-TTGAATTCATGGCCAACATGCAGGGAC 
TGGTGGAAACACCGGAACGA GCTCTC-3' that contained nucleotide substitutions (underlined) to 
convert the first RLE motif to TPE (R10T, L11P) and the reverse primer LEX-CAP2-R (#32 - Appendix 
A). This PCR product was subsequently used to clone into pCI-MYC and pBTM116. The Necabl 
mutant containing the abolished central coiled-coil domain (Necabl2CC) was created via an overlap 
extension mutagenic strategy, involving a two-step PCR reaction, with HA-Necab1 as a template. 
Forward 5'-AACCAGTGGATGACCCAGAAAAATAGACGCCAGAAATTAATTGAT-3' (#153) and 
reverse primers S'-ATCAATTAATTTCTGGCGTCTATTTTTCTGGGTCATCCACTG GTT-3' (#154) 
were constructed in which both contained nucleotide substitutions (underlined) that changed two 
nonpolar residues in the second coiled-coil to polar residues (1218K, L221R) and also created an 
Hsp92 restriction site. Briefly, the first PCR reaction involved amplifying fragments that contained the
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mutated primers, that is using the forward primer #1 25 and reverse primer #154 in one reaction, and 
forward primer #753 and reverse #130 in another. These PCR fragments are complimentary to each 
other in respect to the mutated sequence. Thus, a subsequent second PCR using these purified 
fragments as templates, in addition to the forward #125 and reverse primer #130 resulted in a full- 
length Necabl containing the desired mutation. This final product was cloned into the Not1 site of 
pBTM116, and positive clones containing Necabl 2CC were subsequently screened for the additional 
Hsp92 restriction site. All PCR products were amplified using High Fidelity PCR Supermix (Invitrogen 
Inc.) unless otherwise stated. Clones were subsequently sequenced as described previously.
Yeast Two-Hybrid Interaction Assays
For two-hybrid interaction assays, full length Necabl or carboxyl and amino terminal deletion mutants 
were fused to the VP16 activation domain. CAP1, CAP2 and Necabl were cloned into the LEX fusion 
pBTM116 along with the CAP2 coiled-coil mutant (CAP2tpe). To quantify two-hybrid interactions, liquid 
3-galactosidase assays were performed. Yeast double transformants were grown in 4ml of Yc-ULTK 
+Amp liquid media to an optical density (OD) at 600 nm of greater than 0.500. 1.5 -3.0 mL of cells 
were pelleted and resuspended in Z buffer (60 mM Na2HP04, 40 mM NaH2P04, 10 mM KCI, 1mM 
MgS04, 1 mM DTT), a drop of chloroform and 0.1% SDS was added to each tube and vortexed to 
rupture yeast cells. ONPG (o-Nitrophenyl p-D- galactopyranoside, Sigma) was added to a final 
concentration of 0.8 mg/ml, the time of addition was recorded and tubes were incubated at 30°C until 
a prominent yellow colour developed (24 hour maximum). Once the intensity of the yellow colour 
reached a maximum, the reaction was stopped by adding 500 (jl of 1M sodium bicarbonate and the 
elapsed time was recorded. Tubes were then centrifuged for 1 minute to pellet cell debris, and 1.2 mL 
of supernatant was transferred to a cuvette and absorbance at 420 nm was measured and recorded. 
The amount of P-galactosidase activity was calculated using the equation below and the values of 
three to four trials per clone were averaged.
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Lac Z activity = 1000 * OD420 / 1 * v * OD600
OD420 = absorbance of 1 mL reaction at 420nm
t = time elapsed (minutes)
v = concentration factor
OD600 = absorbance of 1 mL culture at 600nm
RT-PCR
Total RNAfrom brain, kidney, liver, heart, trachea, and lung (Clontech) were reverse transcribed into 
first strand cDNA using an 18-meroligo(dT) primer and Superscriptll reverse transcriptase (Invitrogen 
Inc.) as per manufacturer’s instructions. Briefly, 25 pi reactions containing 0.5 pg of oligo(dT), 1 pg 
RNA, 1 pi 10 mM dNTP mix, and sterile RNase free ddH20  were heated at 65°C for 5 min and chilled 
on ice. 4 pi of 5x first strand buffer, 2 pi 0.1 M DTT, and 1 pi RnaseOUT Recombinant Ribonuclease 
Inhibitor (40 units/pl I) (Life Technologies Inc.) were added and incubated for 2 min at 42°C prior to 
addition o f 1 pi (200 units) of Superscript II and another incubation at 42°C for 50 min. The reaction 
was inactivated by heating at70°Cfor 15 min. PCR products were amplified by using 1 pi of cDNA 
templates, 1 pi of each forward and reverse primer (100 pmol/pl), and 30 pi of PCR Supermix 
(Invitrogen Inc.). PCR reactions first involved a 5 min hot start at 94#C, then 35 cycles of 94°C for 45 
s, 55-58°C for 45 s, 72°C for 1.5 min, and a final extension step of 72°C for 5-7 min. If Necabl mRNA 
was present in tissues a 600 bp fragment would be amplified using the forward primer #93 and the 
reverse primer #99. GAPDH is a constitutively expressed housekeeping gene that was used as a 
control for quality of cDNA, generating a fragment of 750 bp using the forward #52 and reverse primer 
#53. (Appendix A).
Cell culture and Transfections
HEK293 cells were maintained in Dulbecco’s medium (DMEM) (Sigma) supplemented with 10% fetal 
bovine serum (Sigma) and 100 units/ml of penicillin/streptomycin (Invitrogen/Life Technologies). 
HEK293 cells were transiently transfected in 35 mm dishes with 4 pg of denoted plasmid constructs 
via Lipofectamine 2000 reagent (Invitrogen) as per manufacturer’s instructions.
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G ST Fusion Protein Preparations
For GST fusion protein expression, clones in pGEX-KG were transformed into the E. coli expression 
strain BL21-DE3. Protein preparations were prepared from a 5 ml starter overnight at 37°C. After a 
16 hr incubation, starter cultures were diluted 1:100 in 500 ml LB media (in 2L flasks) for approximately 
2 hr until the O.D. reached -0.5. For GST-CAP1, GST-CAP2, and GST-CAP2-N304the temperature 
was them reduced to 30°C and grown for 15 -20 more min. Cultures were then induced with freshly 
made IPTG to a final concentration of 0.2 mM and grown for 4-6 more hours. Each 500 ml culture was 
then spun down and resuspended in 25 ml of phosphate-buffered saline (1*PBS) (14 mM NaCI, 2.7 
mM KCI, 10 mM Na2HP04, 1.75 mM KH2P04, pH 7.4) containing a protease inhibitor cocktail 
(Complete, Roche) and left at 4°C until the next morning. Bacterial cells were then sonicated on ice 
7-8* on setting three, and cells were allowed to cool on ice in between sonications. Triton X-100 was 
added to a final concentration of 0.8% and mixed gently on ice for a half hour to aid in solubilization 
of recombinant proteins. Lysed cells were then centrifuged at 10,000 * g for 15 min, and the 
supernatants from each 25 ml sonicate were incubated with 500 pi of a 50% glutathione-agarose 
slurry for 1 hr at 4°C. Glutathione beads containing the GST-fusion proteins were then washed four 
times for 20 min each with 1 xPBS containing 0.8% Triton X-100. Finally, fusion proteins were eluted 
in Glutathione Elution Buffer (20 mM reduced glutathione, 50 mM Tris, pH 8.0). Eluted proteins were 
then buffer exchanged and concentrated into 1 xPBS using acentricon tube (Fisher). For regular GST 
all growth incubations were done at 37°C, and for GST-Necab1, instead of a 30°C incubation, the 
temperature was 25°C. When necessary, recombinant proteins were cleaved free of GST priortothe 
elution step by incubating beads in Thrombin Cleavage Buffer (20 mM Tris, pH 8.4,150 mM NaCI, 2.5 
mM CaCI2) containing thrombin (Amersham Pharmacia Biotech) (-3 units/1 OOOug of recombinant 
protein), overnight at room temperature. Thrombin was inactivated by the addition of 1 mM PMSF.
Antibodies
An anti-Necab1 rabbit polyclonal antibody was raised againstfull length bacterially expressed Necabl 
cleaved free of GST, and was a kind gift from Dr. Lisa Elferink (University of Texas Medical Branch).
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A rabbit polyclonal anti-CAP2 antibody was raised against the N-terminal 304 amino acids of CAP2 
(CAP2-N304) which was first expressed bacterially as a GST fusion protein and cleaved free of the 
GST. The purified protein was sent off to Covance Inc. where rabbit anti-CAP2-N304 antibodies were 
generated. CAP2 antibodies from whole sera were then affinity purified using CAP2-N304 as an 
antigen on a CNBr-activated Sepharose 4B column (Amersham Biosciences). Other antibodies used 
in this study are as follows: anti-syntaxin1 (HPC-1, Sigma), anti-GST (Sigma), and anti-actin 
(Chemicon). The anti-HA (12CA5), anti-Myc (9E10) antibodies were a kind gift from Dr. Dalian Young 
(University of Calgary).
Western Blot Analysis
For immunoprecipitations 10-20 |jg of proteins were loaded in total extract lanes. Proteins were 
resolved on a 12% SDS-PAGE gel and transferred to nitrocellulose for Western blot analysis. HA and 
MYC tagged proteins were detected using a monoclonal anti-HA antibody 12CA5 (1:10,000 dilution) 
and a monoclonal anti-MYC antibody 9E10 (1:800) respectively. A secondary horseradish peroxidase 
(HRP)-conjugated sheep anti-mouse secondary antibody was then used (1:3300) (Roche). For rat 
tissue samples and brain sections, freshly dissected organs or brain sections were flash frozen in 
liquid nitrogen, ground with a mortar and pestle, and extracted with 2% SDS. Protein (25 pg) samples 
were resolved on 12% SDS-PAGE gels. For detection of endogenous Necabl and CAP2, rabbit 
polyclonal antibodies were used at a dilution of 1:5000 and 10,000 respectively, and a secondary anti­
rabbit IgG HRP conjugate (Promega) was used at a dilution of 1:10,000. The anti-syntaxin1 HPC-1 
antibody was used at a dilution of 1:10,000 anti-actin at a dilution of 1:2000, anti-GST at a dilution of 
1:5000, and all were detected via a secondary horseradish peroxidase (HRP)-conjugated sheep anti­
mouse antibody. Protein concentrations were determined using the Protein Bio-Assay Reagent (Bio- 
Rad). For western blot analysis, proteins were visualized using a Lumi Light chemiluminescence 
detection kit (Roche) as per manufacturer’s instructions. If required, blots were stripped using Restore 
(Pierce) as per manufacturer’s instructions.
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In Vitro Binding Assay
GST-fusion proteins or GST (10 pig) alone immobilized on Glutathione agarose or beads alone were 
incubated with 250 ng of bacterially recombinant Necabl in 300 |jl of Binding Buffer (10 mM Hepes 
pH 7.4,150 mM NaCI, 2 mM MgCI2, 0.2 % Triton X-100,0.5 mM EGTA) for 1.5 hrs at4°C. Glutathione 
beads were then washed 4x at 4°C with 500 pi of Binding Buffer containing 1 % Triton X-100, boiled 
off in sample buffer and subjected to SDS-PAGE. Western blot analysis was performed using a 
polyclonal antibody against hNecabl and GST fusion protein binding was verified by Coomassie blue 
staining or via the use of an anti-GST antibody.
Immunoprecipitation analysis
HEK293 cells were transiently transfected via Lipofectamine 2000 (Invitrogen) in 35 mm dishes as 
described. After leaving DNA/Lipofectamine complex on cells for 6 hrs, cells were trypsinized, and 
replated into 35 mm and 60 mm plates and left for approximately 36 hrs. Cells were then rinsed 
quickly with ice-cold PBS, and scraped off with a cell scraper in RIPA buffer (20 mM Tris pH 7.5,150 
mM NaCI, 10 mM KCI, 1% IGEPAL CA-630 (NP-40), 10% glycerol) containing a protease inhibitor 
cocktail (Complete Mini, Roche). When binding studies involved calcium, immunoprecipitations were 
done in either the presence of 3 mM CaCI2 or in 3 mM of the chelator EGTA. Cell were then briefly 
sonicated on ice and centrifuged for 10 min at 12,000 g at 4°C. Protein concentrations were 
determined using the Protein Bio-Assay Reagent (Bio-Rad). Total protein extracts(200-300 pg) were 
precleared with Protein A agarose beads (Sigma) for 30min in a total volume of 500 pi. Extracts were 
then incubated with Protein A beads that were chemically crosslinked with monoclonal anti-HA 
antibody (12CA5) for 1.5 hrs. Immune complexes were then washed 4x10 min each with 500 pi of 
RIPA minus glycerol and protease inhibitors (or with 3 mM CaCI2 or 3 mM EGTA). The proteins were 
then boiled in 1x sample buffer and analyzed via Western blot analysis using a monoclonal anti-HA 
antibody and a monoclonal anti-MYC antibody (9E10). All immunoprecipitation analysis was carried 
out at 4°C.
33
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Rat Brain Synaptosomal Pull-down Assays
Rat brain synaptosomes were prepared as previously described and all procedures were done at 4°C 
(Chapman et al., 1996; Thomas et al., 1999). Briefly, rat brains were homogenized in 320 mM sucrose 
with a Teflon-glass dounce homogenizer and subsequently centrifuged at 5000 rpm for 2 min in an 
SS34 rotor. The supernatants were collected and spun at 11,000 rpm for 12 min to generate the crude 
synaptosomal pellet. Synaptosomes were then solubilized in buffer B (50 mM HEPES-HCI, pH 7.6, 
100 mM NaCI, and 1% Triton X-100) containing protease inhibitors at a detergent-to-protein ratio of 
10:1 with 10 strokes in a Teflon-glass homogenizer. Homogenized synaptosomes were then mixed 
for 2 hr at4°C and subsequently clarified of insoluble material by centrifugation at 50,000 rpm for 15 
min. Binding studies were performed at 4°C by incubating 800 pg of the cleared solubilized 
synaptosomes in the presence of 3 mM CaCI2 or 3 mM EGTA with 15 pig of the immobilized GST, GST 
fusion proteins, or glutathione-agarose beads alone in buffer C (10 mM HEPES-NaOH, pH 7.4,0.15 
M NaCI, 2 mM MgCI2, and 0.2% Triton X-100). Protein complexes were washed 4* for 10 min each 
in Buffer C (with 3 mM CaCI2 or 3 mM EGTA), boiled in 1 * sample buffer, resolved via SDS-PAGE, and 
analyzed for Western blot using a monoclonal anti-syntaxin 1 (HPC-1) antibody.
Results
Necabl: a Novel Human CAP Interacting Protein
A two hybrid screen of a human adult brain cDNA library, using hCAP2 as a bait revealed ten 
histidine prototroph colonies. Only one of these ten colonies, GAD#5, demonstrated the ability to 
interact with both hCAP1 and hCAP2, and showed no transactivation properties by itself (Table 1). 
Retransformations, along with further two-hybrid analysis of Necabl, revealed that it interacted with 
LEX fusions of hCAP1 and hCAP2, but not with negative control baits such as LEX-Lamin, LEX-BAT, 
LEX-BAT313, and LEX-BAT380N (Figure 4). Upon sequencing and performing a BLASTX search, 
GAD#5 was shown to encode a protein that shared homology with a rat protein named Neuronal 
Calcium Binding Protein 1 (Necabl) (GenBank AF 193756, Sugita and Sudhof, 2001). Further
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Table 1: Analysis of clones isolated from yeast two-hybrid 






Interaction w ith  
LEXCAP1
1 NO NO NO
2 NO NO NO
3 NO YES NO
4 NO NO NO
5 NO YES YES
6 YES YES NO
7 NO YES NO
8 NO NO NO
9 YES YES NO
10 NO NO NO
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Figure 4. Two-hybrid analysis o f Necabl fo llow ing retransformations. The original clone 
GAD10#5, that encoded a partial clone of human Necabl (GAD10Necab1) was tested against 
numerous bait plasmids in the (3-galactosidase colony filter assay using LacZ as a substrate. Positive 
interactions are denoted by a blue colour and the intensity of the interaction can be corelated with 
colour intensity.
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analysis revealed that GAD#5 did not contain the full length sequence of Necabl, but was missing the 
5' end. A subsequent BLASTN search of the Human Genome Project database was performed to 
obtain the chromosomal sequence. Analysis of this sequence along with the full length sequence of 
rat Necabl (GenBank A F 193755), lead to the determination that 12 base pairs were missing from 
GAD#5. Primers were designed to PCR full length Necabl from the brain cDNA library. This PCR 
product was subsequently cloned into pBS (Stratagene) and sequenced.
Analysis of the full length protein sequence of Necabl (Figure 5A), reveals an N-terminal 
calcium binding domain (EF-hand), and three coiled-coil domain in tandem (Figure 5B). Coiled-coil 
domains are thought to mediate protein-protein interactions with coiled-coils of other proteins, and 
even act as homo-dimerization domains (Burkhardetal., 2001). Further analysis of the central coiled- 
coil motif reveals that it is a potential SNARE motif, as Necabl has homology to the neuronal SNAREs 
in this region (Figure 5C). The t- and r-SNAREs have been reclassified into Q- and R-SNAREs based 
on conserved structural motifs (Fasshauer et al., 1998). This was based on amino acid sequence 
alignment o f the conserved residues from the crystal structure of the SNARE complex. Specifically, 
each SNARE contributes an amphipathic a-helix to the complex, and alignment within reveals a layer 
of highly conserved hydrophobic residues. Upon closer inspection, a zero layer of ionic residues 
occupying the centre of the a-helices of all SNAREs is evident. This ionic residue can be either 
arginine (R) or glutamine (Q); thus, the designation of the names. The SNARE complex has been 
shown to constitute three Q-SNAREs and one R-SNARE. Alignment of the central Necabl coiled-coil 
(residues 207-260) with the hydrophobic layer of the neuronal SNAREs reveals that Necabl shares 
homology, specifically with synaptobrevin (a v-SNARE). Within the zero layer of Necabl, the residue 
is a lysine instead of an arginine, but this change is tolerated as a synaptobrevin family member also 
contains a lysine at the zero layer (Fasshauer et al., 1998).
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Figure 5. Analysis o f the amino acid sequence o f human Necabl and SNARE alignment. A,
Complete 351 amino acid sequence of N ecab l The EF-hand motif is highlighted in red, and 
coiled-coil domains are highlighted in green. The amino acid sequence that was used to perform the 
SNARE alignment is highlighted in bold and underlined. 6, domain structure of Necabl drawn to 
scale. The N-terminal EF-hand {EF) is shown in red, with the three repetitive coiled-coils (CC) are 
highlighted in green. Coiled-coils were predicted using the COILS Server at 
http://www.ch.embnet.org/software/COILS_form.html. Numbers indicate the amino acid residues that 
border each of the respective domains. C, Alignment of the four neuronal SNAREs motifs based on 
their respective hydrophobic layers. hNECABI (hNECABI; 207-260) was aligned against these 
segments in like manner. Sx1a (syntaxin 1a; 202-255); SN1 (SNAP-25; 28-82); SN2 (SNAP-25; 
148-203), Sb2 (synaptobrevin; 31-85). The core layers that comprise the 15-layered hydrophobic 
environment of the amphipathic bundle are boxed in green and the ionic, zero (0) layer residue 
indicated in red.
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Necabl is Preferentially Expressed in Brain Along with CAP2
To further aid in deducing the function of Necabl and CAP2, rabbit polyclonal antibodies 
against both proteins were developed. The antibody againstfull-length Necabl reacts specifically with 
recombinant Necabl and an endogenous protein of approximately 42 kDa, since Anti-Necab1 
antibodies preabsorbed with GST-Necab1 do not (Figure 6A). No specific immunoreactivity was seen 
with preimmune serum (results not shown). A rabbit polyclonal antibody against CAP2 was generated 
using the first 304 amino acids as an antigen. Preimmune serum does not show any specific reactivity 
(results not shown). The CAP2 antibody reacts specifically with HA-tagged CAP2 and CAP2-N304 
(antigen used for the antibody), and an endogenous protein of approximately 58 kDa, but does not 
demonstrate any cross-reactivity with HA-CAP1 (Figure 6B). The band above 79 kDa in Figure 6B 
is a non-specific band. Anti-CAP2 antibodies react specifically with the 58 kDa band in rat brain, while 
antibodies that have been immunodepleted with GST-CAP2-N304 do not (Figure 6C).
In order to deduce NecabTs tissue expression, RT-PCR was performed on total human RNA 
using specific primers. RT-PCR results revealed that Necabl mRNA is preferentially and highly 
expressed within the human brain, but with lower levels in kidney, trachea and lung (Figure 7A). 
GAPDH was used as a control for cDNA quality and quantification. Further analysis of Necabl 
expression within rat organs and tissues was performed using the anti-Necab1 rabbit polyclonal 
antibody. Western blot analysis demonstrated similar RT-PCR results, except that no Necabl 
expression was seen in rat kidney, and Necabl was also detected within spinal cord (not tested in RT- 
PCR) (Figure 7B). Actin was used as a control for protein sample quality and as a loading control. 
Further analysis of rat brain regions reveals that Necabl and CAP2 have a similar brain expression 
pattern (Figure 7C). Both are highly expressed within the frontal and posterior cortexes and the 
hippocampus, and both are expressed at low levels in the medulla, pons, and spinal cord. Necabl 
and CAP2 expression only differs within the cerebellum, as CAP2 is present whereas Necabl is 
absent, agreeing with published reports on Necabl (Sugita et al., 2002). Actin was used as a protein 
loading control, and syntaxin 1 as a positive control, agreeing with previously published results (Chen 
etal., 1999).
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Figure 6. Specificity of the anti-Necab1 and anti-CAP2 polyclonal antibodies. A.anti-Necabl 
antibody shows specific immunoreactivity in brain extract Anti-Necab1 antibodies (Anti-Necab1)  or 
those preabsorbed with the GST-Necab1 antigen (Cleared) were used for Western blot to detect 
recombinant and endogenous Necabl. Note that immunoreactivity is almost abolished in the Cleared 
blot and the band in Brain extract is only present in Anti-Necab1. B, specificity of the anti-CAP2 
antibodies. Rat Brain and mammalian cell extracts expressing empty vector (HA), HA-tagged CAP1, 
CAP2, or the antigen used for the antibody - CAP2-N304 (N304) - were loaded on SDS-PAGE. 
Western blot analysis was performed using anti-HA or the anti-CAP2 antibodies. Note that anti-CAP2 
antibody only reacts with CAP2 and N304, but not CAP1, and specifically reacts with a band in Brain 
extract not present in the HA blot. C, immunodepleted anti-CAP2 antibodies (Cleared) do not react 
with CAP2. Blots were performed as in A, except that mammalian extracts expressing empty vector 
(HA) or HA-CAP2 were used. Note that the Cleared antibodies react with other bands, but not with 
those specific for Anti-CAP2. Approximate protein standard sizes are indicated in kDa.
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Figure 7. Necabl tissue expression and sim ilar brain distributions o f Necabl and CAP2. A,
RT-PCR of Necabl expression. Total RNA of different human tissues was used to make cDNA and 
PCR products were amplified using specific primers. GAPDH was used a positive control for quality 
of cDNA. Base pair sizes are indicated at side of gel. B, western blot of Necabl expression in rat 
tissues. Tissues were extracted in SDS buffer and 25 ug of protein was loaded on SDS-PAGE and 
immunoblotted using anti-Necabl, and anti-actin as control for both quality and amount of protein 
loaded. C, Brain distribution of Necabl and CAP2. Brain regions were dissected, extracted with SDS 
buffer and 25 ug loaded on 12% SDS-PAGE. Blot were probed with anti-Necabl, anti-CAP2, 
anti-Syntaxin 1 as a control for proper distribution, and anti-actin as a control for amount of protein 
loaded.
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Necabl • CAP2 Interaction is Specific and Dependent on Coiled-coil Domains
In order to demonstrate that Necabl is indeed a genuine binding partner of the human CAPs, 
we performed in vitro binding studies using recombinant bacterially expressed proteins. As 
demonstrated in Figure 8A, Necabl directly interacts with both CAP1 and CAP2, but not GST or 
beads alone, in which proteins have been immobilized onto glutathione beads as shown by the 
coomassie blue stain to the left. The * denotes GST-CAP1 that have been degraded within the C- 
terminus as it is still pulled down by the glutathione beads and was also verified by performing anti- 
GST western blot (results not shown). The in vitro interaction fortified Necabl as a CAP binding 
partner and lead us to further characterize the interaction in vivo using mammalian cells lysates 
expressing HA and MYC-tagged proteins. Interestingly, immunoprecipitation o f HA-Necab1 using the 
anti-HA antibody (12CA5) demonstrates that the interaction may be specific for CAP2 since CAP1 
does not show any interaction with Necabl in vivo (Figure 8B). Cell lysates from HEK293 cells 
expressing HA- and MYC-tagged proteins reveals that all constructs are expressed and 
immunoprecipitations reveal that MYC-CAP2 does not bind without the presence of HA-Necab1.
To further characterize the interaction between human CAPs and N ecabl, we mapped the 
interaction domains necessary for binding using the yeast two-hybrid system. Different deletion 
mutants of Necabl were constructed and expressed as fusions with the VP16 activation domain, such 
that both carboxyl and amino terminal deletion mutants had three variations of coiled coil organization 
(see schematic in Figure 9). These deletion mutants were then tested for their ability to interact with 
the LEXCAP1 and CAP2 fusions containing the DNA binding domain in the yeast two hybrid system 
(Figure 9). Results demonstrated that the N-terminal 250 amino acids (N250) of Necabl containing 
the first two coiled-coils interacted with both CAPs, while N284 containing a small C-terminal deletion 
showed a reduced interaction which may be explained by protein instability. N200 that contained only 
the first coiled-coil did not exhibit any interaction. Furthermore, C156 containing only the last two 
coiled-coils, demonstrated a substantial interaction, while C100 does not Since results suggested that 
the central coiled-coil of Necabl is where CAP binding occurs, a mutant of Necabl was constructed 
via site-directed mutagenesis that had this domain abolished (Necabl2CC). N e c a b l^  does not
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Figure 8. In vitro  and in vivo interaction between CAPs and Necabl. A, in vitro binding of 
bacterially expressed His-Necab1 to immobilized GST-hCAPs. 250 ng of His-Necab1 was incubated 
with immobilized GST-fusions on glutathione-agarose beads or beads alone {Beads). Beads were 
washed extensively with binding buffer, boiled off in sample buffer and subjected to SDS-PAGE and 
Western blot analysis using a polyclonal antibody against N ecabl Coomassie blue stains were 
performed to verify binding of GST-fusion proteins to glutathione-agarose and is depicted to the right 
(* denotes a C-terminally degrade product of GST-CAP1 since the fusion protein is pulled down by 
glutathione agarose beads). B, in vivo interaction demonstrating Necabl co-immunoprecipitates 
hCAP2 but not hCAP1. HEK293 cells were transiently transfected with hemaglutammin (HA) or MYC 
tagged constructs. Protein extracts were incubated with pre-conjugated 12CA5 (anti-HA) Protein-A 
beads. Immune complexes were washed extensively with RIPA buffer and boiled off in sample buffer. 
Protein extracts samples (Extracts) along with immunoprecipitations (IP) were subjected to 
SDS-PAGE, and western blot analysis was performed using anti-HA (12CA5) or anti-MYC (9E10) 
antibodies. Presence (+) and abscence (-) of constructs used is denoted. Approximate protein 
standard sizes are indicated in kDa.
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Figure 9. Two-hybrid mapping o f Necabl-CAPs interaction domains. A schematic of full length 
Necabl, deletion mutants, and a mutant in which the second coiled has been mutated (1218K, L221R; 
Necabl2CC) are illustrated on the left. The EF-hand calcium binding domain (EF), and the three 
predicted coiled-coil domains (CC) in tandem repeat are denoted. The interaction of these 
VP16-Necab1 constructs were tested in a yeast two-hyrid assay with LEX-CAP1 and LEX-CAP2. The 
G-galactosidase activity of each interaction was quantified using ONPG (o-Nitrophenyl 
li-D-galactopyranoside) as a substrate, normalized, and expressed as a percentage of the activity of 
full-length N ecab l The amino acid residues are shown as numbers next to each construct Results 
are representative of three to four trials, and the mean standard error (±) of each interaction is shown 
as a percentage.
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demonstrate any substantial interaction with either of the hCAPs (Figure 9), indicating that the central 
coiled-coil domain of Necabl is essential for hCAP binding.
Since Necabl likely bound to the human CAPs through its central coiled-coil domain and that 
CAPs also contain an N-terminal coiled-coil, suggested the interaction may be coiled-coil mediated. 
Thus, a mutant of CAP2 was created via one step site directed mutagenesis PCR strategy with the 
coiled-coil structure abolished (CAP2tpe). All CAPs have a conserved N-terminal domain termed the 
RLE motif, due to three highly conserved residues that are thoughtto constitute the coiled-coil structure 
(Hubberstey and Mottillo, 2002). Changing the charged arginine to an uncharged polar threonine, and 
the leucine to proline changes the secondary structure, and results in the abolishment of the coiled-coil 
structure (Nishidaetal., 1998). The LEX fusion of the CAP2 coiled-coil mutant (R10T, L11P) along with 
wild-type CAP2, were tested for their ability to interact with VP16Necab1 in the two-hybrid system 
(Figure 10A). Results demonstrated thatwild-type CAP2 can interact with Necabl, while CAP2TPE does 
not. As a positive control, we employed VP16CAP1 to demonstrate that the coiled-coil mutant is 
expressed properly and is still capable of interacting with proteins. We further tested the ability of 
CAP2tpe to interact with Necabl in vivo. Immunoprecipitation analysis reveals that CAP2 interacts with 
Necabl through its N-terminal coiled-coil (Figure 10B). Immunoprecipitation of HA-Necab1 using the 
anti-HA antibody (12CA5) demonstrates thatwild-type CAP2 interacts with Necabl but the coiled-coil 
mutant does not. Western analysis reveals that all constructs are expressed properly (Figure 10B). 
Therefore, Necabl and CAP2 interact through a coiled-coil mechanism.
Necabl Dimerizes Independent o f Calcium
Analysis of Necabl revealed only a single EF-hand within the N-terminus. Since most calcium 
binding proteins contain at least two EF-hands, it was postulated that Necabl could dimerize in order 
to bind calcium. Single EF-hand domain proteins can form homodimers in order to bind Ca2* (Lewit- 
Bentley and Rety, 2000). Therefore, in vivo binding studies were performed in order to test whether 
Necabl could interact with itself. HEK293 cells were cotransfected with HA- and MYC-tagged Necabl 
and immunoprecipitations using anti-HA antibodies were performed in the presence of 3 mM CaCI2
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Figure 10. The Necabl-CAP2 interaction is mediated through coiled-coil domains. A, mutation 
of the CAP2 coiled-coil domain necessary for Necabl binding. A schematic on the left illustrates the 
highly conserved residues (RLE) of wild-type {WT) CAP2 necessary for the coiled-coil structure, and 
those same residues (TPE) in the mutant (R10T, L11P; CAP2tpe) in which the coiled-coil structure is 
abolished. The interaction of these LEX-CAP2 constructs were tested in a two-hybrid assay with 
VP16-Necab1, and VP16-CAP2 which was used as a positive control for the interaction with CAP2tpe. 
The interactions were quantified as stated in Figure 9 except that the activity is stated in arbitrary units 
(a.u.) and the mean standard error is shown. The amino acid residues are shown as numbers next to 
each construct. Results are representative of three to four trials, and the mean standard error (±) of 
each interaction is shown as a percentage. B, immunoprecipitation analysis reveals that CAP2's 
coiled-coil is necessary for binding Necabl in vivo. Immunoprecipitations were performed as described 
in Figure 8B. Presence (+) and absence (-) of constructs used is denoted. Approximate protein 
standard sizes are indicated in kDa.
52




1 Ro 12 —I
i RLE
CAP2tpe 
1 10 12 
I I tp e I






















+ - + -
+ - +
Figure 10.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
or in the presence of the chelator EGTA (3 mM) (Figure 11 A). Surprisingly, results demonstrated that 
Necabl can indeed dimerize, however, the interaction is calcium independent. The dimerization 
between HA-CAP1 and MYC-CAP1 was used as a positive control, and no MYC-Necab1 binds without 
the presence of HA-Necab1. Western analysis reveals that all constructs are expressed properly. The 
domain necessary for Necabl dimerization was mapped using similar VP16 deletion mutants of Necabl 
used to map the CAP binding domain. These activation domains fusions were tested for their ability 
to interact with the DNA binding domain fusion of LEXNecabl in the P-galactosidase colony filter assay 
(Figure 11B). Positive interactions are denoted by a blue colour. All constructs tested demonstrated 
a positive interaction, except Necabl-C100 that expresses only the last coiled-coil. This establishes 
that Necabl dimerization is likely mediated through its first two N-terminal coiled-coils. Though, the 
involvement of the EF-hand in mediating the dimerization cannot be excluded.
Necabl Associates with the Neuronal SNARE Syntaxin 1a
Necabl was first isolated through its ability to associate with neuronal synaptotagmin 1 through 
affinity chromatography (Sugita et al., 2002; Sugita and Sudhof, 2000). However, this interaction was 
not shown to be physiologically significant, as an in vivo interaction was not demonstrated (Sugita et 
al., 2002). Prior to these results being published, we also wanted to further characterize the 
Synaptotagmin 1 - Necabl interaction, and also found that it does not occur in vivo (results not shown). 
We hypothesized that Necabl could possibly bind to neuronal SNAREs due to its SNARE homology. 
Necabl is a putative R-SNARE, and R-SNAREs bind specifically to Q-SNAREs, suggestive to the idea 
that that Necabl could interact with a Q-SNARE such as syntaxin 1 a. In order to test this, in vivo rat 
brain synaptosomal pull-down assays were performed. This assay involves immobilizing GST-Necab1 
onto glutathione-agarose beads and incubating solubilized synaptic vesicle enriched brain extracts 
(synaptosomes) to pull down endogenous protein complexes. GST pull-down assays demonstrated
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Figure 11. Necabl dimerization and domain mapping. A, Immunoprecipitational analysis 
demonstrating that Necabl can dimerize independent of calcium (Ca2+). Bindings were performed as 
described in Figure 8B, except that IPs were done in the presence (+) of 3 mM CaCI2 or containing 3 
mM EGTA (-). Presence (+) and absence (-) of constructs used is denoted. Approximate protein 
standard sizes are indicated in kDa. B, two-hybrid mapping of Necabl dimerization domains to the first 
two coiled-coils. Mapping was performed as described in Figure 9, except that the Necabl-LEX fusion 
was used and the (3-galactosidase colony filter assay was performed as described in Figure 4. 
Positive interactions are denoted by a blue colour.
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that Necabl bound Syntaxin 1a in vivo in a calcium independent manner (Figure 12A). Results also 
suggest that Necabl may associate with syntaxin 1a at the membrane, as syntaxin 1a is an integral 
membrane protein and synaptosomes are a membrane enriched fraction. GST itself did not 
demonstrate the ability to pull-down substantial syntaxin 1a and neither did beads alone. To further 
characterize the calcium dependance of the interaction GST or GST-Necab1 were incubated with 
increasing |jM concentrations of free Ca2+and solubilized synaptosomes. Results demonstrated that 
Ca2+does not have any effect on the Syntaxin 1a - Necabl interaction (Figure 12B).
To determine if Necabl and syntaxin 1 a directly interact with each other, in vitro binding studies 
were performed using recombinant proteins. Immobilized GST, GST-syntaxin 1 a, or beads alone, were 
incubated with bacterially produced Necabl, and protein complexes were verified by performing a 
western against Necabl. Only GST-syntaxin 1a binds Necabl, while GST or beads alone do not 
(Figure 12C). GST and fusion proteins were verified for bead binding by performing a western against 
GST. We further hypothesized that Necabl - Syntaxin 1a binding occurred through Syntaxin’s Q- 
SNARE motif since Necabl was a putative R-SNARE. As shown in Figure 12D, Necabl can 
specifically bind to the immobilized GST-H3 SNARE motif of Syntaxin 1 a, but once again it cannot bind 
to GST or glutathione beads alone. Therefore, Necabl can physiologically interact with the SNARE 
syntaxin 1a which is likely mediated through SNARE binding.
Discussion
In this study, novel CAP interacting protein named Neuronal Calcium Binding protein 1 
(Necabl) was isolated and characterized. The interaction is physiologically specific to CAP2, although 
CAP1 can also interact in the two-hybrid system. The specific brain expression pattern and calcium 
binding properties of Necabl suggests that it may have a function during long term potentiation. More 
importantly, it may modulate a neuronal function of CAP2. We also demonstrated that Necabl is a 
physiological binding partner of the neuronal SNARE syntaxin 1 a; suggestive of a function for Necabl 
during synaptic transmission. Thus, we suggest Necabl may serve to link CAP2 to neuronal function.
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Figure 12. Interaction o f Syntaxin 1a with Necabl is independent o f calcium and mediated 
through its SNARE motif. A, in vivo interaction of Necabl with endogenous Syntaxin 1a using rat 
synaptosomal GST pull-down assays. The cytoplasmic domain of synaptotagmin (GST-Syf) or 
hNecabl (GST-nNecab) were expressed as GST fusion proteins, immobilized onto glutathione-agarose 
beads and incubated with detergent solubilized rat brain synaptosomal extracts in the presence 1 mM 
Ca2* or 1mM EGTA. Glutathione beads containing protein complexes were washed with appropriate 
buffers, boiled off in sample buffer and loaded on SDS-PAGE. Western blot analysis (Wn. Ab) using 
an anti-syntaxin 1 mouse monoclonal antibody (anti-Stx) were then performed. GST and beads alone 
(Con) were used as negative controls and GST-Syt as a positive control. B, the Necabl - Syntaxin 1a 
interaction is not affected by increasing calcium concentrations. Immobilized GST- hNecab or GST 
alone were incubated with detergent solubilized rat brain in the absence {EGTA) or presence of the 
indicated amounts of free Ca2+. Bindings and western blot analysis were performed as described in A. 
C, interaction of Necabl with Syntaxin 1a is independent of other proteins. Immobilized GST or the 
cytoplasmic domain of syntaxin 1 a (GST-Stx) or beads alone (Con) were incubated with recombinant 
hNecabl and binding studies were performed as described in Figure 8A. Western blot analysis was 
performed using anti-hNecab and anti-GST antibodies (Wn. Ab). GST alone (GST) or beads only (Con) 
were used as controls. D, the Necabl -Syntaxin 1 a interaction is mediated through Syntaxin’s SNARE 
motif. Binding and explanation is as described in 12C, except thatthe SNARE motif of syntaxin 1 a (H3) 
was used rather than the cytoplasmic domain.
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The Association of CAP2 with Necabl Implies a Neuronal Function
Necabl is a recently characterized calcium binding protein, with an unknown function (Sugita 
et al., 2002). It is a member of a family of calcium binding proteins that are primarily expressed within 
the brain with the existence of two other orthologues, Necab2 (Bernier et al., 2001) and Necab3 (Lee 
et al., 2000). Specifically, Necabl has been shown to have restricted neuronal expression, as it is 
highly expressed within layer 4 of pyramidal neurons of the cerebral cortex, and within the 
hippocampus, where only inhibitory neurons and pyramidal neurons of the CA2 region reveal Necabl 
expression (Sugita et al., 2002). These results suggest that Necabl likely has a specialized function 
within the brain. We have independently isolated and characterized Necabl through its ability to 
interact with human CAP2 in a yeast two-hybrid library screen. Necabl is a protein of approximately 
42 kDathatcontains an N-terminal EF-hand, and three predicted repetitive coiled-coil domains. Binding 
studies reveal that Necabl binds both CAP1 and CAP2 in vitro and in the two-hybrid system, but only 
associates with CAP2 in vivo. The in vivo interaction with CAP2 suggests that it is physiologically 
relevant, while the interaction with CAP1 may not be relevant. This does not rule out other possibilities, 
as CAP1 may be complexed with other proteins and unable to interact with Necabl, or that the 
interaction with CAP1 is tightly regulated and a regulatory signal is needed for an interaction to occur.
The interaction between CAP2 and Necabl has been mapped and is mediated through coiled- 
coils domains. This is suggestive of a specific interaction, as domains necessary for eliciting protein- 
protein interactions are involved (Burkhard et al., 2001). The specificity of the interaction was also 
demonstrated in the initial two-hybrid as Necabl was not able to interact with other proteins. We have 
determined that Necabl is highly and preferentially expressed within the brain of both human and rat. 
RT-PCR from human tissues show that Necabl exhibits lower levels of expression within trachea, and 
even lower expression within kidney and lung. Western blot analysis demonstrates a similar 
expression, except no Necabl is detected within rat kidney. This could simply be explained by a 
difference in expression of Necabl between human and rat, as the orthologue Necab3 (XB51) 
demonstrates different expression patterns between these two organisms (Lee et al., 2000). In 
addition, western blot analysis is not as sensitive of a technique as RT-PCR. Another possibility is that
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the kidney mRNA is expressed but the protein is not. The contradictory results are not likely due to 
non-specific primer binding or non-specific antibody interaction, as both primers were designed against 
a sequence specific for Necabl, and the antibody specifically detects overexpressed HA-Necab1 and 
an endogenous band of -42 kDa. Also, antibodies that were pre-absorbed with GST-Necab1 do not 
demonstrate any specific immunoreactivity. The results that we present differ from those published on 
Necabl by Sugita et al., who demonstrated that Necabl is expressed only within the brain (Sugita et 
al., 2002). We are confident that our results reveal the true expression pattern of Necabl. Firstly, 
Sugita et al. used Northern and Western analysis to look at the expression of Necabl. RT-PCR is 
similar in specificity to Northern analysis, but is more sensitive, since in theory, if a single mRNA 
molecule is expressed it will be detected by PCR. Secondly, the specificity of our antibody is revealed 
in the fact that our brain expression pattern of Necabl agrees with that of Sugita et al., whom 
demonstrated that Necabl is highly expressed in the cerebral cortex and hippocampus, but not 
expressed in the cerebellum (Sugita et al., 2002). Thirdly, the expression in trachea was not studied 
by Sugita et al. Thus, the discrepancies in Necabl expression can probably be explained due to 
different techniques employed. Different sized bands were observed in the western blot analysis of 
Necabl protein expression (Figure 7B) and cannot be fully ruled out as alternatively spliced isoforms 
since northern blot analysis is performed.
The expression of CAP2 mRNA differs from CAP1 which is more ubiquitously expressed, 
suggestive that CAP2 may have a more specific, refined role in actin reorganization (Swiston et al.,
1995). CAP2 mRNA is expressed highly in testes and brain, with moderate levels in heart and skeletal 
muscle, andfower levels in kidney, small intestine, lung and skin. Interestingly, Necabl and CAP2 are 
both expressed in tissues where regulated secretion occurs (i.e. brain and kidney). The similar and 
specific expression pattern for Necabl and CAP2 in brain is highly suggestive of a specialized function. 
Both are highly expressed within the cerebral cortex and hippocampus, and at lower levels in the 
medulla, pons, and spinal cord. Furthermore, this fortifies the idea that the CAPs are more than just 
mere ubiquitously expressed housekeeping proteins, but instead are spatially regulated; indicative of 
a specific function. This idea is in agreement with other studies as the Drosophila CAP homologue is
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spatially regulated (Baum et al., 2000; Baum and Perrimon, 2001); additionally CAP is also 
developmental^ regulated in Xenopus (KhosrowShahian et al., 2002).
The expression of Necabl within the cerebral cortex and hippocampus has been localized to 
pyramidal excitatory pyramidal neurons, with additional expression in inhibitory interneurons of the 
hippocampus (Sugita et al., 2002). This is highly intriguing, since excitatory pyramidal neurons act as 
a convergence point to organize all the inputs that are received from axons of other neurons. 
Specifically, hippocampal pyramidal neurons of the CA [cornu ammonis) region is where the process 
of long term potentiation (LTP) is localized. LTP is a prolonged enhancement of synaptic strength, and 
is thought to be the fundamental mechanism behind learning and memory formation. Necabl is 
particularly expressed in the CA2 region of the hippocampus (Sugita et al., 2002). The function of the 
CA2 field is unclear, but it function in slow transmission, directing signals from the CA3 region to CA1 
(Sekino et al., 1997). The fact that Necabl and CAP2 are physiological binding partners, and highly 
expressed within the cerebral cortex and hippocampus, is suggestive to a neuronal role for CAP2 that 
is likely moderated through Necabl. The possibility that Necabl is simply just a Ca2+ buffering protein 
is highly unlikely, as Ca2+ buffering proteins are usually of very small molecular weight and are 
composed of mainly just one EF-hand (Caillard et al., 2000; Hof et al., 1999). EF-handscan also act 
to modulated a protein binding region in response to Ca2+ binding, which is the case with calmodulin 
(Lewit-Bentley and Rety, 2000). In addition to its EF-hand, Necabl contains multiple coiled-coil 
domains and bears R-SNARE homology, thus the possibility to form multiple protein-protein 
interactions. Hence, it would be intriguing to speculate that NecabTs EF-hand acts to mediate its 
protein interactions through Ca2+signalling. That Necabl may be an effector of CAP2 during neuronal 
function is not unconventional, as other examples exist of proteins having specific neuronal modulators. 
Calcineurin has been shown to modulate the function of dynamin 1 during synaptic vesicle exocytosis 
(Lai et al., 1999). Dynamin functions during endocytosis with other proteins in order to facilitate 
pinching of vesicles from the plasma membrane. This calcium-dependent interaction with calcineurin 
results in a calcium-sensing mechanism for internalization of synaptic vesicles. The possible functional 
and neuronal role for the Necabl - CAP2 interaction will be further discussed in Chapter Four and Five.
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Necabl is a Potential Effector of Synaptic Transmission
It is evidentthat many of the protein-protein interactions involved in vesicle docking, fusion and SNARE 
regulation, are mediated through coiled-coil domains (Brunger, 2000). Necabl contains an R-SNARE 
homology motif, and R-SNAREs bind to Q-SNAREs. Interestingly, we have demonstrated that Necabl 
is a physiological binding partner of the neuronal Q-SNARE syntaxin 1 a and that the interaction occurs 
through syntaxin’s SNARE motif. Thus, it is highly conceivable that Necabl binds to syntaxin through 
this domain. Interestingly, this is the domain where CAP binding has been mapped. Whether or not 
these interactions of Necabl are independent of each other, remains to be resolved. Nevertheless, if 
Necabl does bind syntaxin through its central coiled-coil, this would potentially interfere with CAP2 
binding.
Necabl dimerization was demonstrated to be calcium independent, and may function as a 
manner of regulating its interaction with other proteins. Necabl's affinity for itself is very high as is 
evident from the two-hybrid results. Thus, Necabl homodimerization may be a preferred state, and in 
this state binding of other proteins may be prevented, as dimerization likely forms through the first two 
coiled-coils. The alleviation of the dimer would allow Necabl to bind other proteins. Necabl 
dimerization was first postulated to be a manner in which it could bind calcium, since it is a single EF- 
hand protein. Although this was not demonstrated, as dimerization occurred in the absence of calcium, 
the possibility still exists that calcium binding occurs when Necabl homodimerizes. Necabl may also 
form higher order multimer structures, however, this would have to be verified by size-exclusion 
chromatography.
Necabl's connection to the t-SNARE syntaxin 1 a is very intriguing. Syntaxin 1 a, along with the 
other neuronal SNAREs SNAP-25, and synaptobrevin, constitute the complex necessary for fusion of 
synaptic vesicles. Furthermore, Necabl's specific expression within the cortex and hippocampus 
suggests a role in long term potentiation; a specific form of neuronal communication that results in a 
postsynaptic enhancement. It is plausible that Necabl provides a link between SNARE function and 
LTP since postsynaptic membrane fusion and LTP have been associated. The correlation between 
membrane fusion and LTP has been demonstrated by the introduction of blockers of synaptic fusion
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within hippocampal neurons. These blockers such as peptide inhibitors, and botulinum toxin reduced 
the induction of LTP (Lledo et al., 1998). Additionally, introduction of SNAP into the postsynapse, an 
activator of synaptic transmission, resulted in a mechanistic enhancement similar to what occurs during 
LTP (Lledo et al., 1998). Thus, themolecularmachinerythatregulatesexocytosisispresentwithinthe 
postsynapse of dendrites and acts to provoke LTP. Two scenarios exist where membrane fusion can 
function during LTP. Firstly, the machinery is thought to be involved in transport of a retrograde 
messenger that increases the probability of release (Malenka and Nicoll, 1999). In this case, the 
exocytic machinery would be made more competent to neuronal stimulation and result in an increase 
of neurotransmitter release. Secondly, the delivery and/or insertion of additional glutamate receptors 
within the postsynaptic membrane is thought to result in an increase in synaptic strength (Lledo et al., 
1998). In agreement, the insertion and movement of new a-amino-3-hydroxy-5-methyl-4- 
isoxazolepropionic (AMPA) receptors occurs through SNARE-dependent exocytosis during LTP 
(Borgdorff and Choquet, 2002; Lu et al., 2001). Thus, it is plausible that Necabl could modify vesicle 
fusion machinery in either the pre- and/or postsynapse, thereby resulting in an increase in synaptic 
strength.
The idea that Necabl is a SNARE effector is not outlandish, as regulators of SNARE function 
do exist. For example, SNIP1 is a binding partner of SNAP-25 and acts to tether SNAP-25 to the 
submembranous actin cytoskeleton (Chin et al., 2000). Another SNAP-25 binding partner, spring, acts 
to regulate neurosecretion by inhibiting the formation of the SNARE complex (Li et al., 2001). In 
addition, amisyn, a syntaxin 1a binding protein, also regulates the formation of the SNARE complex 
(Scales et al., 2002). Moreover, the genetic connection between CAP and the yeast synaptobrevin 
homologue SNC1, suggests that CAP may function during SNARE dependent events.
64
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
CHAPTER THREE 
Subcellular Localization of CAP2 and Necabl
Introduction
The actin binding proteins, CAPs, contain a central poly-proline region, which is a protein 
interaction module that binds SH3 domains of other proteins (Mayer, 2001; McPherson, 1999). The 
yeast CAP poly-proline stretch binds SH3 domains of other proteins, and specifically bind Abp1 through 
this domain. Additionally, localization studies revealed that the poly-proline region is important for CAP 
targeting to cortical actin patches (Freeman et al., 1996). This localization was demonstrated to be 
dependent upon Abp1, as studies in an abp1- strain revealed that yeast CAP does not localize to 
cortical actin patches (Lila and Drubin, 1997). Further proof of the interaction-dependent localization 
was demonstrated through the inability of a poly-proline mutant of CAP to localize to cortical actin 
cytoskeleton patches.
The importance of a protein’s localization is exemplified by the syntaxin family which display 
different subcellular localizations which correlate to different cellular functions (Teng et al., 2001). The 
Syntaxins (Stxs) mediate the fusion of vesicles on different organelles along the exocytic and endocytic 
pathways. For example, Stx 1 a and b are localized to the presynaptic plasma membrane, and mediate 
the release o f neurotransmitter vesicles. The more ubiquitously expressed Stx 5, localized to ER-Golgi 
boundary, and Stx 7 and 8, localized to endosomes, function during ER-Golgi transport and late 
endosome fusion; respectively. A second example is actin and its binding proteins through their 
localization to dendritic spines and neurite outgrowths (Kuhnetal., 2000; Luo, 2002; Smart and Halpain, 
2000). Actin, ADF/cofilin, ARP2/3, VASP, and WASP are localized to neuron growth cones, and are 
also either present, or predicted to be at dendritic spines. The presence and function of these proteins 
correlates with the role for the actin cytoskeleton in outgrowths, and maintenance of spine stability. 
Thus, characterizing a protein’s subcellular localization provides insight into its function.
In part due to the localization-dependant function of yeast CAP, we wanted to characterize the 
subcellular localization of human CAP2 and Necabl, in hopes of gaining insight into their functions and
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the subcellular compartments of their interactions. We had previously shown that Necabl interacted 
with membrane bound Syntaxin 1 a (Chapter Two), which suggests that this interaction occurs at the 
plasma membrane. Previous studies (Vojtek and Cooper, 1993), in addition to our own overexpression 
studies in mammalian cells, have shown the hCAPs to be mainly cytosolic proteins. We further wanted 
to identify if CAP2 and Necabl were localized to the plasma membrane, as this would suggest a 
function during membrane dependent process of vesicle exocytosis. Thus, subcellular fractionation 
studies were performed on mammalian cells overexpressing tagged HA-Necab1 and MYC-CAP2, and 
also on the endogenous proteins, in rat brain. It is demonstrated that Necabl and CAP2 act mainly as 
soluble cytoplasmic proteins, but also have a membrane localization which is resistant to extraction. 
In the rat neuronal cell line PC12, it is demonstrated that endogenous CAP2 is localized to neurite 
extensions, where it co-localizes with overexpressed Necabl, but not with F-actin.
Materials and Methods
Cell Culture and Transfections
PC12 cells were maintained in DMEM supplemented with 10% FBS, 5% horse serum (Sigma), and 
100 units/ml of penicillin/streptomycin (Invitrogen/Life Technologies) in a humidified 5% C02 
atmosphere at 37°C. HEK293 cells were transiently transfected in 35 mm dishes with 4 |jg  each of 
pCI-HA-Necab1 and pCI-MYC-CAP2 expression plasmids via Lipofectamine 2000 reagent 
(Invitrogen/Life Technologies) as per manufacturer’s instructions. PC12 cells were transfected at 90% 
confluency in 35 mm dishes with empty vector (pCI-HA) or HA-Necab1 with 4 pig of pCI-HA-Necab1 
and 10 pi of Lipofectamine 2000 for 6 hr, as per manufacturer’s instruction.
Subcellular Fractionations
Subcellular fractionation of HEK293 cells was carried out as per Kessels et a/.(Kessels et al., 2000), 
with slight modifications. HEK293 cells were transiently transfected with HA-Necab1 and MYC-CAP2, 
as described above in two 35 mm dishes, and after the 6 hr incubation with the Lipofectamine - DNA
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complex, were trypsinized off and replated into one 100 mm plate. 36 hrs post-transfection, confluent 
cells from two 100 mm plates were rinsed in ice-cold 1 *PBS, and scraped off in 750 |jl homogenization 
buffer (250 mM sucrose, 10 mM EGTA, 2mM EDTA, 20 mM Tris pH 7.5 plus protease inhibitor 
cocktail)/plate. Cells were then homogenized with 50 strokes of a glass/Teflon dounce homogenizer, 
and subsequently passed through a 25 gauge needle 20*. Homogenates were centrifuged at 3000 * 
g for 20 min to give S1 and P1, which contains unbroken cells, nuclei, mitochondria, and large pieces 
of plasma membrane. The first wash of P1 was pooled with the S1 fraction, andS1 was subsequently 
centrifuged for 30 min at 25,000 * g to give S2 and P2, which contains small pieces of plasma 
membrane, endoplasmic reticulum, and endosomes. S2 was centrifuged at 176,000 x g for 1 hr, to give 
P3 which contains light microsomes and small vesicles, and S3 which contains soluble, cytosolic 
proteins. Pellets were washed twice with homogenization buffer. Protein concentrations were 
determined using the Protein Bio-Assay Reagent (Bio-Rad), and 25 pg of each fractions was resolved 
on SDS-PAGE. Western blot analysis was performed using antibodies against HA, MYC, and actin 
as described in Chapter Two. Pyruvate kinase (1:5000) was used as a cytosolic marker, and AP2 
(1:2000) was used as a membrane and vesicle marker. Results are representative of three trials. For 
endogenous localization in brain, a frozen rat brain was diced and homogenized in a similar manner 
in 6 ml of homogenization buffer, and the same procedure was performed.
Rat Membrane Extractions
For rat brain membrane extractions, procedure was followed as per Scales eta/, and references therein 
(Scales et al., 2002). Fractionations were performed by homogenizing a rat brain in 7 ml of HB buffer 
(20 mM Hepes pH 7.2,10 mM sucrose,10 mM KCI, 2mM EDTA, 2 mM EGTA, 6 mM MgCI2, 1 mM 
dithiothreitol plus protease inhibitor cocktail) with fifty strokes of a dounce homogenizer, and 
subsequently passing through a twenty-gauge needle 10x. Homogenates (H) were centrifuged for 15 
min at 1000 *  g to give a post nuclear supernatant (PNS) which was then subsequently centrifuged at 
20,000 x g for 15 min to give a membrane pellet (/W), and a 20,000 x g cytosol (20k-C). The membrane 
pellet was washed once with 10 ml of HB buffer and then resuspended in 5 ml of buffer. 20k-C was
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then centrifuged for 1 hr at 100,000 * g to generate a supernatant that contained true, soluble proteins 
(C). Forthe membrane extractions, the resuspended membrane pelletwas aliquoted into 1 ml fractions 
in 2 ml micro-ultracentrifuge tubes, and 1 ml of one of the following was added to the tubes: distilled 
water as a negative control, 3 M NaCI, 4 M Urea, 0.4 M Sodium Bicarbonate pH 11, or 4% Triton X-100. 
The solutions were left on ice for 30 min to extract membranes, then subsequently centrifuged for 1 hr 
at 100,000 x g to generate a supernatant (S) and an insoluble pellet (P). The pellets were then 
subsequently resuspended in 2 ml of HB buffer, and equal portions of each S and P were fractionated 
via SDS-PAGE. Western blot analysis was then performed using anti-Necab1, anti-CAP2, anti-syntaxin 
1a, and anti-Pyruvate Kinase antibodies as described.
Immunocytochemistry and Confocal Microscopy
6 hr post-transfection, PC12 cells were plated into Lab-Tek permanox chamber slides (Nalge-Nunc) 
that were coated with Matrigel basement membrane matrix (Becton Dickinson) (diluted 1:50) at approx. 
30% confluency. Cells were differentiated for 4-5 days in DMEM containing 1% FBS, 0.5% HS plus 
penicillin/streptomycin, and 75-80 ng/ml nerve growth factor (NGF) (Sigma). After differentiation, cells 
were fixed in freshly prepared formaldehyde diluted to 3.7% in 1 x PBS, and subsequently permeabilized 
in 0.5% Triton X-100 in 1 xPBS. For detection of HA-tagged Necabl, the anti-HA monoclonal antibody 
(12CA5) was diluted 1:200 in 1xPBS, and visualized with an Alexa 568 conjugated goat anti-mouse 
secondary antibody (1:2000) (Molecular Probes) in 1 xPBS. For detection of endogenous CAP2, anti- 
CAP2 rabbit polyclonal antibodies were diluted 1:40, and detected via a secondary Alexa 488 
conjugated goat anti-rabbit secondary antibody (1:500) (Molecular Probes). F-actin filaments were 
visualized with Alexa 568-phalloidin (Molecular Probes), diluted 1:50 in 1 xPBS. After rinsing in 1 xPBS 
0.05% Tween 20, once in 1xPBS, and briefly in distilled water, coverslips were placed on a drop of 
Slow Fade Light anti-fade reagent (Molecular Probes) and mounted on a microscope slide and sealed 
with nail polish. Visualization of subcellular localization was achieved using an MRC 1024 laser 
scanning confocal microscope (Bio-Rad). Images were processed using Confocal Assistant. Pre- 
immune sera and CAP2 antibodies clarified with GST-CAP2-N304 were used as controls for
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immunofluorescence.
Results
Necabl and CAP2 are Cytosolic Proteins tha t also show a Membrane Localization
Inordertofurtherunderstand the function of Necabl and CAP2,subcellularfractionations were 
performed in HEK293 cells overexpressing both proteins. As Figure 13A illustrates, Necabl and 
CAP2 act mainly as cytosolic proteins, as they are mostly present in the supernatants, but are also 
presentin comparable amounts in other fractions. Specifically, a substantial amount of Necabl is found 
in P1 which contains large pieces of plasma membrane and nuclei. With CAP2, a substantial amount 
is found associated with P3 which contains microsomes and vesicles. Actin is not concentrated in any 
particular fraction, but is present in lower amounts in P3. The cytosolic protein Pyruvate Kinase (PK) 
was used to ensure proper cell disruption had occurred, and is concentrated only in supernatants. 
Alpha-adaptin 2 (AP2) was used as a membrane and vesicle compartment marker, and is only found 
within pellets. Since the antibodies against Necabl and CAP2 were developed, the localization of the 
endogenous proteins was studied to validate the overexpression results. Fractionations were 
performed as with HEK293 cells, except that rat brain was used. As shown in Figure 13B, results for 
endogenous Necabl and CAP2 agree with those of the overexpression studies. The proteins are 
mainly cytosolic, but also demonstrate some localization to other fractions. Specifically, a substantial 
amount of CAP2 is found in the microsomal/vesicle pellet, agreeing with the overexpression 
fractionation.
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Figure 13. Subcellular localization o f CAP2 and Necabl. A, Subcellular fractionation of cells 
ovexpressing Necabl andCAP2. HEK293 cells were co-transfected with HA-Necab1 andMYC-CAP2 
and cells were subsequently fractionated via differential centrifugation. P1 contains unbroken cells, 
nuclei, mitochondria, and large pieces of plasma membrane, P2 contains small pieces of plasma 
membrane, endoplasmic reticulum, and endosomes, P3 contains light microsomes and small vesicles, 
and, S3 contains soluble, cytosolic proteins. Equal protein amounts of each fraction were then 
separated via SDS-PAGE and analysed by western blot for indicated proteins. Pyruvate Kinase (PK) 
was used as a cytoplasmic marker and AP-2 as a microsomal and membrane compartment marker. 
S, supernatant, P, pellet. Results are representative of three trials. B, subcellular fractionation of 
endogenous Necabl and CAP2 in rat brain. Fractionations were performed as in A, except that 
western blot analysis using the anti-Necab1 and CAP2 antibodies was performed, demonstrating similar 
results. H, homogenate.
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The association of Necabl with syntaxin 1a, led to the proposition that Necabl may be 
localized to the plasma membrane; similarly with CAP2. Rat brain fractionations were performed to 
study the endogenous proteins and their presence in membrane fractions. Differential fractionation was 
performed to obtain a post-nuclear supernatant, membrane pellet, and cytosol. Necabl and CAP2 
once again behave as soluble proteins, as they are enriched in the cytosolic (C) fraction, but also 
display some membrane localization (M), similar to that of membrane bound syntaxin 1a (Figure 14A). 
Pyruvate Kinase was used as a cytoplasmic control, and demonstrates little membrane localization 
which can be considered background. To ensure that membrane enriched Necabl and CAP2 are 
indeed membrane associated and tightly bound, membrane extractions were performed using different 
solute conditions. The membrane pellets from Figure 14A were extracted with either a control buffer, 
1.5 M NaCI, 2M Urea, 0.2 M Sodium Bicarbonate pH 11, or 2% Triton X-100. As Figure 14B 
demonstrates, the membrane bound Necabl and CAP2 resist extraction in the same manner as that 
of syntaxin 1 a, which agrees with previously published reports (Scales et al., 2002). On the other hand, 
the cytoplasmic marker PK is washed out with control buffer, pH 11, and is completely extracted with 
Triton X-100. These results demonstrate that membrane enriched Necabl and CAP2 are indeed tightly 
bound, and do not represent background cytosolic proteins.
CAP2 is Localized to Neurites and Co-localizes with Necabl, but not F-Actin
In order to gain further insight into a possible neuronal role for CAP2, immunocytochemistry 
on adrenal pheochromocytoma PC12 cells differentiated with nerve growth factor (NGF)was performed. 
Use of the anti-CAP2 antibodies demonstrated that CAP2 has a cytosolic localization within the cell 
body, but is also localized and concentrated to neurite outgrowths (arrowheads) (Figure 15A, B and 
C). The tips of neurite outgrowths contain filopodia and lamellipodia which are regions of high actin 
turnover. Pre-immune serum does not show any signal (Figure 15D), and neither do anti-CAP2 
antibodies that were pre-absorbed with GST-CAP2-N304 (Figure 15E), demonstrating that the 
localization in 15A, B and C, is specific to CAP2. The localization of CAP2 with F-actin filaments and
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Figure 14. D istribution of endogenous Necabl and CAP2 in rat brain fractions. A, Necabl and 
CAP2 are mainly cytosolic. A rat brain was homogenized (H) and fractionated to obtain the following: 
PNS, post nuclear supernatant; M, membrane pellet; 20k-C, 20,000 * g cytosol; and C, 100,000 * g 
cytosol, containing soluble proteins. 8, membrane fractions of Necabl and CAP2 resist extraction. The 
membrane pellet from A  were divided in equal parts and extracted with different conditions. Treatments 
are as follows, Con, control buffer; NaCI, 1.5 M NaCI; Urea, 2 M urea; pH 11,0.2 M sodium bicarbonate, 
pH 11.0; or TX100,2% Triton X-100. Aliquots representing an equal percentage of each supernatant 
(S) and pellet (P) were loaded on 12% SDS-PAGE and immunoblotted with indicated antibodies. 
Syntaxin 1 was used as a positive control for the membrane fraction and extractions, and pyruvate 
kinase (PK) was used as a negative control.
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Figure 15. Localization o f CAP2 in NGF-differentiated PC12 cells. A, B, and C endogenous 
distribution of CAP2. PC12 cells were differentiated with 75 ng/ml of NGF over a five day period. 
Immunocytochemistry was performed using the anti-CAP2 polyclonal antibody and visualized via an 
secondary Alexa-488 anti-rabbit antibody conjugate. Arrowheads point to neurite tips where CAP2 is 
highly localized. D, preimmune serum was used instead of the anti-CAP2 antibodies and does not 
result in any significant signal. E, anti-CAP2 antibodies were preabsorbed with GST-CAP2-N304 and 
used for immunocytochemistry. No signal is observed indicating the immunolocalizations in A, B and 
C are specific to CAP2.
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Necabl was also studied. Cells were stained for endogenous CAP2 and also for filamentous actin 
using an Alexa 568-phalloidin conjugate. Double labelling of cells shows the network of F-actin 
filaments (Figure 16A and D) and endogenous CAP2 (16B and E). The merged images reveals that 
CAP2 and F-actin do not co-localize, even though both are highly concentrated within neurites (16C 
and F). Arrowheads in these images depict examples where F-actin is localized to the very tips of 
outgrowths, with CAP2 localized to the periphery. Much to our surprise and lament, we were unable 
to find a cell line that expressed Necabl (results not shown). Therefore, to study the co-localization 
of Necabl and CAP2, PC12s were transfected with HA-Necab1 and double labelling experiments were 
performed with endogenous CAP2. Figure 16G and J demonstrate that Necabl is present throughout 
the cytoplasm, and within neurites, agreeing with previously published reports (Sugita et al., 2002). In 
the same cells, CAP2 is once again present within the cell body, and concentrated to neurites (16H and 
K). The merged images demonstrate the co-localization (yellow) of Necabl and CAP2to neurites, and 
to a lesser degree within the cell body (161 and L). It is important to note that Necabl is found at the 
very tip of neurite extensions, while CAP2 is not (arrowheads).
Discussion
In this study, we demonstrate that Necabl and CAP2 are mainly cytosolic proteins, but a 
fraction is also tightly bound to the plasma membrane. Immunolocalization studies in differentiated 
PC12s, reveals that CAP2 is concentrated to neurite outgrowths where itco-localizes with Necabl, but 
not F-actin. Overall, results demonstrate that both proteins are localized to regions where calcium 
mediated exocytosis and neurite outgrowth occurs, in which the dynamics of the actin cytoskeleton is 
essential to both processes.
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Figure 16. CAP2 co-localizes with Necabl but not with F-Actin in NGF-differentiated PC12 cells.
PC12 cells were treated as in Figure 15 except that HA-Necab1 was visualized with the anti-HA 
antibody and an Alexa-568 secondary conjugate, and F-actin via Alexa 568-Phalloidin. Distribution of 
F-actin (A, D), and overexpressed HA-Necab1 (G,J), with endogenous CAP2 (6, E, H, K) in 
differentiated PC12s via double immunofluorescence labelling of cells. The superimposed images of 
F-actin and CAP2 (C, F) demonstrates that their distribution does not overlap, while that of Necabl and 
CAP2 does (/, L). Note, arrowheads point to examples of the very tip of neurites where CAP2 does not 
co-localize with F-actin (C, F) or Necabl (/, L).
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Co-Localization of Necabl and CAP2 Suggests a Role in Neuronal Function
We have demonstrated that Necabl and CAP2 are cytosolic proteins that are also associated 
with the lipid membrane. Interestingly, since Necabl can associate with syntaxin 1 a in vivo (Chapter 
Two), this could be one manner in which it is localized to the plasma membrane. It is doubtful that 
Necabl is associated with the membrane through weak electrostatic bonds, as it is not extracted with 
NaCI or pH 11.0 which are known to disrupt such interactions (Scales et al., 2002). This suggests that 
the localization may occur through covalent bonds. A mechanism for NecabTs membrane localization 
may occur through two predicted N-myristoylation sites (PROSITE motif search). Whether CAP2 is 
bound to the plasma membrane through syntaxin 1 a is highly unlikely; we are unaware of any SNARE 
like motif within CAPs, and the mechanism of its localization can only be speculated. One possibility 
is that it may occur through the lipid messenger PIP2. In Dictyostelium, CAP has been shown to have 
its actin binding properties inhibited by PIP2,and is dependent upon the N-terminus of CAP (Gottwald 
et al., 1996). Further study of Dictyostelium CAP, reveals that its N-terminus is essential in localizing 
the protein to plasma membrane regions, and this property is independent of the poly-proline region 
(Noegel et al., 1999). Thus, PIP2 may be important for the membrane localization of CAPs in general, 
though no proof exists for an interaction in mammalian homologues.
The membrane enrichment of CAP2 and Necabl within rat brain is an important result, as it 
localizes these proteins to areas of neurotransmitter release. Also, brain fractionations revealed that 
a substantial amount of CAP2 is found within the vesicle/microsomal pellet, suggestive of CAP2 being 
associated with vesicles. Interestingly, the HIPs are actin binding proteins that are also associated with 
vesicles (McPherson, 2002). During neurotransmitter release the function is strengthened by the co­
localization of Necabl and CAP2 to neurites in NGF-differentiated PC12 cells. PC12 are rat brain cells 
of a neuroendocrine lineage that have many characteristics of sympathetic neurons, such as the 
release of neurotransmitter, and response to nerve growth factor (Greene and Tischler, 1976). Thus, 
they are a good model system for the study of basic neurobiology. Within such cells, the actin 
cytoskeleton is known to be present at the active zone of the presynaptic terminal of neurons. It is 
thought to act as a structural component of the terminal, forming a scaffold at the last step prior to
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vesicle priming. The belief is that a dynamic change would be needed in the actin cytoskeleton which 
would then allow the transition to the last stage (Morales et al., 2000). This dynamic change has been 
demonstrated to occur through the GTPase Rac. Following the docking of vesicles, Rac acts through 
a yet unknown membrane effector(s), to allow the fusion competence of exocytosis (Humeau et al., 
2002). The possibility that CAP2 may be a downstream effector in this signalling pathway will be 
discussed in Chapter Five. The co-localization of Necabl and CAP2 also suggests a role during 
neurite outgrowth. Numerous proteins involved in the turnover of actin filaments also function in 
outgrowth of neurite extensions (Luo, 2002). These are areas of high actin turnover, and since CAPs 
are important regulators of actin dynamics; perhaps CAPs also have a function in this process. 
Interestingly, both Necabl and CAP2 demonstrate an increase in expression during postnatal brain 
development. Necabl is present at the embryonic stage and its expression substantially increases 
postnatally (Sugita et al., 2002). CAP2 has been reported to have a postnatal increase in expression 
within the brain (Fukuda et al., 2002). These results bode well with the idea that both proteins are 
involved in synaptogenesis, as other proteins that function during synapse formation display a similar 
expression pattern (Sugita et al., 2001). In vertebrates, the overall structure and makeup of the brain 
is formed prenatally, but synapses in brain are formed postnatally, which correlates with the dramatic 
postnatal increase in expression of synaptic proteins, such as synapsin, synaptobrevin 2, 
synaptotagmin 1, and synaptophysin (Daly and Ziff, 1997). Thus, CAP2 and Necabl may have a 
similar function in the formation of synapses in immature neurons, and the maintenance of synaptic 
connections in mature neurons.
Different theories exist for the functional role of CAPs; one is that they act merely as actin 
monomer sequester proteins, thus acting to negatively regulate F-actin turnover (Gieselmann and 
Mann, 1992; Gottwald et al., 1996), while another theory is that they play a more active role in actin 
dynamics; acting as a monomer delivery molecules, thus aiding in the turnover of actin filaments 
(Moriyama and Yahara, 2002). ThatCAP2 does not co-localize with actin filaments structures within 
neurites supports the former theory. On the other hand, the fact that CAP2 is localized to the very 
periphery of F-actin rich networks lends support to the latter theory. In this case, CAP2 could assume
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an active role in the delivery of monomers to these highly dynamic actin-rich structures. Thus, we 
suggest an amalgamation of these two ideas where the CAPs act to determine the spatial and temporal 
distribution of actin filaments; capable of preventing the formation of actin filaments, and when required, 
also promoting their formation. The form of role that CAPs assume would be dependent upon cell type, 
cellular processes and possibly even cell signalling events. This idea is supported by studies on the 
Drosophila homologue of CAP, capulet. Capulet was identified through a search for genes required 
for Drosophila oocyte polarity (Baum et al., 2000). Capulet germline clones had additional actin rich 
structures especially at polar sites, where the protein would normally localize, thus demonstrating that 
capulet accumulates in areas of the oocytes to inhibit actin polymerization. Furthermore, capulet was 
shown to function in limiting the formation of actin filaments in Drosophila epithelial cells (Baum and 
Perrimon, 2001). This role was antagonist to the function of cofilin and profilin, both proteins that 
promote the turnover of actin filaments. Another study that independently isolated Drosophila CAP, 
demonstrated that it is required to prevent the formation of actin filaments within the eye disc (Benlali 
et al., 2000). Thus, the distribution and actin binding properties of CAP2 would have to be meticulously 
regulated in order to maintain a proper functioning actin cytoskeleton. In further support of this theory, 
we made the observation that PC12 cells containing high levels of CAP2, had few actin filaments. In 
contrast, cells with large amounts of actin filaments expressed low levels of CAP2 (results not shown). 
Interestingly, Necabl co-localizes with CAP2 at neurites, but is also found at the very tips where 
filopodia and lamellipodia are active. One possibility is that Necabl may act as a modulator of CAP2's 
actin binding properties. How actin binding in mammalian CAPs is regulated is still a mystery. Necabl 
may be an additional regulatory mechanism of CAP2 within neurons; preventing it from sequestering 
actin and disrupting dynamic actin structures at the very apex of neurite outgrowths. The functional 
aspects of the CAP2 - Necabl interaction will be further addressed within Chapter Four and Five. 
Finally, our inability to find any cell line that expresses Necabl, suggests that Necabl has an important 
physiological role that is not manifested within a cell line, but this role may be present in the grand 
scheme of neuronal function.
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CHAPTER FOUR
Potential Functional Role for the CAP2 - Necabl Interaction in Neuronal Processes
Introduction
It is becoming clear that the actin cytoskeleton has an important role in the development and 
formation of neurons, and furthermore, their subsequent maintenance and function (Luo, 2002; Smart 
and Halpain, 2000). This is apparent, as the actin network involved in the formation of morphological 
structures such as filopodia, microvilli, and stereocilia, is also involved in the formation of neurons, and 
more specialized structure such as dendritic spines (Rao and Craig, 2000). For example, the neck of 
dendritic spines resembles structures of microvilli and sterocilia, actin rich structures of the post­
synaptic density resemble that of filopodia, and the filamentous network within mature spine heads 
resembles that of lamellipodia (Rao and Craig, 2000). Similarly, proteins such as ARP2/3, cofilin, 
profilin, WASP, and Ena/VASP which function in the formation of basic actin networks, are also 
proposed to function in the morphological changes that occur in dendritic spines.
The array of actin binding proteins within the brain constitutes a manner in which these proteins 
need to be controlled, and different measures of control exist. One important regulatory mechanism 
of actin dynamics in the brain is LIMK1 which acts to phosphorylate and inactivate cofilin (Bamburg, 
1999). Phosphorylation is a post-translational modification, and is one manner in which proteins are 
able to be regulated. Phosphorylation is carried out by a catalytic enzyme termed a protein kinase that 
can transfer a phosphate group from ATP, and incorporate it into another protein. The result is either 
a negative (inactivating), or positive (activating) effect on that target protein. Alternatively, a 
phosphatase can remove a phosphate from the protein, thus acting antagonistically to the kinase. The 
significance with regards to LIMK1, is that it allows it to act as a negative regulator in the turnover of 
actin filaments. Additional discovery of the regulatory mechanism in actin dynamics will provide a 
clearer picture on the function of the actin cytoskeleton.
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In yeast, CAP is known to be involved in a cell signalling cascade involving Ras and its effector 
adenylyl cyclase, but this has not been demonstrated to occur in other eukaryotes. The concept of 
human CAPs linking cell signalling events to the dynamics of the cytoskeleton is not fully apparent 
outside of yeast and the manner in which CAPs in general are regulated is unknown. Therefore, the 
possibility that CAP2 was regulated at the level of phosphorylation, and thus involved in acell signalling 
cascade was explored. In vivo labelling assays reveal thatCAP2 is indeed phosphorylated and occurs 
within the C-terminal 232 amino acids. In addition, through immunoprecipitation analysis it is revealed 
that when CAP2 is bound to Necabl, it is unable to bind actin. Furthermore, through the use of actin 
polymerization assays, it is for the first time demonstrated that CAP2 is a potent inhibitor of actin 
polymerization. Necabl does not seem to have any effect on the ability of CAP2 to bind G-actin in this 
assay, though Necabl itself has a substantial inhibitory effect.
Materials and Methods
Molecular Cloning
The pCI-HA-CAP2-N304 clone was constructed by using the forward primer#31 and the reverse primer 
#109 (Appendix A) in a PCR reaction, using pCI-HA-CAP2 full-length as a template. pCI-HA-CAP2- 
C232 was constructed using the forward primer #108 and the reverse primer #32 (Appendix A) in a 
as described earlier. The PCR fragments were subsequently digested with EcoR1 and Xho1 and 
ligated into pCI-HA cut with the same restriction enzymes.
Functional Immunoprecipitation
The immunoprecipitations were performed as desribed in Chapter Two, except that the anti-HA 
antibody was not preconjugated to Protein-A beads. Briefly, HEK293 cells were transfected as 
described in Chapter Two. Cells lysates were prepared in RIPA buffer, and 200-300 pg of total protein 
extract were brought up to a volume of 250 pi of RIPA, and 250 pi of RIPA containing either 6 mM
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CaCI2,or6 mM EGTA was added for a total volume of 500 pil. Extracts were then incubated with Protein 
A beads and precleared for 30 min. Precleared extracts were then incubated with the anti-HA (12CA5) 
antibody for 1 hr, and immune complexes were collected by the addition of Protein A beads, and 
incubated for another hour. Immune complexes were then washed 4* for 10 min each with 500 pi of 
RIPA buffer containing either 3 mM CaCI2 or 3 mM EGTA, boiled off in 1 * sample buffer and analyzed 
via Western blot analysis using a monoclonal anti-HA, anti-MYC, and anti-Actin antibody. All 
immunoprecipitations were carried out at 4°C.
Actin Polymerization Assays
The Actin Polymerization Biochemistry Kit (#BK003 Cytoskeleton Inc.) was used to study the effect of 
CAP2 and Necabl on actin polymerization using pyrene-labeled actin (10% of total actin). GST protein 
preparations were performed as described in Chapter Two, except that proteins were concentrated, 
and buffer exchanged into Storage Buffer (10 mM Tris, pH 8.0, 25 mM NaCI, 1 mM DTT + 10% 
glycerol). Recombinant Necabl used in this study was cleaved free of GST. Prior to performing actin 
polymerization assays, lyophilized G-actin was resuspended in Buffer A (5 mM Tris, pH 8.0,0.2 mM 
CaCI2, 0.01 % NaN3, and 0.2 mM ATP) and incubated overnight at 4°C to ensure full depolymerization 
of G-actin. The next day G-actin was centrifuged at 150,000 x g for 1 hr at 4°C to remove any 
nucleating centres. A Varian Eclipse fluorescence spectrophotometer was set at the following 
conditions to measure polymerization: excitation wavelength at 365 nm with a 10 nm slit bandwidth; 
emission wavelength set at 407 nm wavelength with a 10 nm slit bandwidth, and the PMT voltage set 
at medium. The concentration of G-actin to protein studied, was set at a 1:1 ratio. 4 piM G-actin (10% 
pyrene labelled) was incubated with 4 piM of GST, GST-CAP2, Necabl, GST-CAP2 + Necabl, or 
Storage Buffer alone with the addition of Supplementary Buffer (3.45 mM Tris, pH 8.0,0.262 mM ATP, 
0.262 CaCI2), so that a final low salt buffer was constituted (5 mM Tris, pH 8.0,0.2 mM CaCI2, 0.2 mM 
ATP, 4.8 mM NaCI, 1.9% glycerol). This 400 |jl mixture was allowed to incubate and equilibrate at 
25°C for 30 min. After incubating for 30 min, 40 jjI of 10* Actin Polymerization Buffer (500 mM KCI, 
20mM MgCI2,10 mM ATP) was mixed and transferred to a 500 (jl quartz fluorometric cuvette and the
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kinetics of the reaction was measured by reading the fluorescence (arbitrary units) every minute for a 
total of 55 min at 25°C. The time required to mix the proteins with Actin Polymerization Buffer and 
transfer to cuvette was noted, and a standard time was allotted from the point of mixing, to the point of 
fluorometer reading. Raw data was entered into Microsoft Excel, where the Fluorescence (arbitrary 
units) was plotted against time (minutes).
In Vivo Phosphorylation Assays
HEK293 cells were transfected via Lipofectamine 2000 in 60 mm dishes, 24 hr prior, with the pCI-HA 
constructs of CAP2, CAP2-N304, and CAP2-C232 as described in Chapter Two. Cells were rinsed 
twice with phosphate-free Dulbecco’s modified Eagle’s medium (Life Technologies) containing 10% 
FBS, and subsequently phosphate starved in the same media for 15 min. Cells were once again rinsed 
with phosphate free media, plated in1.2 ml of media, then 32P04 (1 0  mCi/ml, in H20; Amersham 
Pharmacia Biotech Inc.) was added directly to the cells at a final concentration of 0.3 pCi/ml, and 
incubated at 37°C with gentle agitation every 30 min for 4 hr. After incubation, cells were rinsed twice 
with ice cold 1 *PBS and scraped off in RIPA buffer (20 mM Tris pH 7.5,150 mM NaCI, 10 mM KCI, 1 % 
IGEPAL CA-630 (NP-40), 10% glycerol) containing a protease inhibitor cocktail (Complete Mini, 
Roche), and briefly sonicated on ice. Extracts were then clarified by centrifuging at 12,000 x g for 10 
min at 4°C. 300 |jg of protein were then brought up to final volume of 500 pi with RIPA, and IPs were 
performed as described in Chapter Two. Cell extracts samples (25 pig) and IPs were then separated 
on SDS-PAGE, and transferred to nitrocellulose membrane. The membrane was then exposed to 
autoradiography film for five days and subsequently developed. Western blot analysis using the anti- 
HA antibody was then performed on the same membrane to ensure the proper expression and 
immunoprecipitation of fusion proteins.
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Results
Necabl Inhibits CAP2 Actin Binding
In order to understand the functional purpose of the Necab1-CAP2 interaction, an 
immunoprecipitation was performed to study the effect calcium had on the interaction, and what effect 
Necabl had on the actin binding properties of CAP2. The IPs were performed as in Chapter Two; HA- 
Necabl and MYC-CAP2 were co-expressed in mammalian cells, and HA-tagged proteins and 
complexes were immunoprecipitated using the anti-HA antibody. As Figure 17 demonstrates, the 
addition of 3 mM CaCI2 to the RIPA buffer did not have a substantial effect on the interaction between 
Necabl and CAP2 (first two lanes of IP). Furthermore, no actin is pulled down in the complex with 
Necabl and CAP2, suggesting that when the proteins interact, Necabl prevents CAP2 from binding 
actin in a calcium independent manner. Necabl itself does not demonstrate any actin binding 
properties, with or without the presence of Ca2+ (lanes three and four of IP). As a control for actin 
binding, CAP2 bound actin, and is not affected by Ca2+ (lanes five and six of IP). The Extracts lane 
reveals that all proteins are properly expressed. Therefore Necabl, independent of Ca2+, interacts with 
CAP2 and prevents actin binding.
CAP2 is a Potent Inhibitor of Actin Polymerization
To further study whether CAP2 and/or Necabl can affect actin dynamics, actin polymerization 
assays were performed. These assays are based on the enhanced fluorescence that occurs when 
pyrene labelled G-actin polymerizes into pyrene F-actin. As the pyrene labels come in closer contact 
with each other, an increase in fluorescence is observed. An important factor in the equilibrium 
between G and F-actin is the Critical Concentration (CC), described as the actin monomer 
concentration below which actin will not polymerize. By changing conditions of ionic type and strength, 
this affects the CC. For example at low ionic strength the CC is high, but upon addition of Mg2+and KCI, 
the CC decreases substantially. Thus, increasing ionic strength, can induce the polymerization of actin. 
This increase in fluorescence can be followed overtime by the use of a flourescent spectrophotometer.
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Figure 17. Functional Immunoprecipitation of Necabl with CAP2 and Actin. Bindings were 
performed in a similar manner as described in Figure 8B. HEK293 cells extracts expressing HA- 
and/or MYC-tagged fusion proteins were prepared in RIPA buffer. Protein extracts were then prepared 
in the presence of 3 mM CaCI2 (Ca2++) or containing 3 mM EGTA (Ca2+ -) and incubated with anti-HA 
antibody. Immune complexes were then subsequently collected by the addition of Protein-A beads. 
Complexes were washed extensively with RIPA buffer containing 3 mM CaCI2 or 3 mM EGTA and 
boiled off in sample buffer. Protein extracts samples (Extracts) along with immunoprecipitations {IP) 
were subjected to SDS-PAGE, and western blot analysis was performed using anti-HA (12CA5), 
anti-MYC (9E10), or anti-actin antibodies. Presence (+) and absence (-) of constructs used is denoted. 
Arrows to the right of blots indicate bands that correspond to indicated fusion proteins, while other 
bands represent the heavy chain of the anti-HA antibody. Note: the curving of protein bands is an 
artifact of the gel.
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Recombinant proteins of GST-CAP2 and Necabl (GST-cleaved) were produced to study their effect 
on actin polymerization, and whether any cooperative or inhibitory interactions would occur. As Figure 
18 demonstrates, addition of Buffer alone (Storage Buffer) demonstrates a typical curve of actin 
polymerization. This also verified that Storage Buffer alone did not alter the kinetics of polymerization, 
in addition to it having no increase in fluorescence prior to the addition of Actin Polymerization Buffer 
(results not shown). What effect the addition of proteins would have on actin polymerization at a ratio 
of 1:1 G-actin was then studied. GST alone, as a control, had a small effect on limiting the rate of actin 
polymerization and was used to standardize the background. Conversely, GST-CAP2 was a potent 
inhibitor of actin polymerization, as demonstrated by the lack of fluorescence. Surprisingly, the addition 
of Necabl, resulted in a substantial decrease in the polymerization of actin. This is an unexpected 
result as we are unaware of any actin binding motifs within Necabl, and no actin binding was 
demonstrated in immunoprecipitational analysis. Furthermore, Necabl does not seem to alter the 
ability of CAP2 to inhibit actin polymerization when both proteins are studied together in the assay. 
Thus, results demonstrate that CAP2 inhibits the formation of F-actin, and this effect is not alleviated 
by the addition of N ecabl
CAP2 is a Phosphorylation Target
Little information is known about how CAPs are regulated, and whether or not CAPs are 
phosphorylated. Thus, in vivo phosphorylation assays, wherein HEK293 cells were transfected with 
different HA-CAP2 constructs, and subsequently cultured in the presence of radioactive ortho­
phosphate were performed. Cells were transfected with HA-tagged full-length CAP2, an N-terminal 
mutant expressing the first 304 amino acids (CAP2-N304), and a C-terminal mutant expressing the last 
232 amino acids (CAP2-C232). After labelling, immunoprecipitations were performed on extracts, 
proteins were subjected to SDS-PAGE, transferred to nitrocellulose, and exposed to autoradiography 
film. Surprisingly, wild-type CAP2 and CAP2-C232 are phosphorylated, while CAP2-N304 is not 
(Figure 19A). Interestingly, the C-terminal deletion mutant seems to be highly phosphorylated when 
compared to wild-type CAP2. As a control, immunoprecipitation from cells extracts expressing
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Figure 18. Actin Polymerization Assays of CAP2 and Necabl. Different GST-tagged fusion 
proteins or buffer alone were incubated with pyrene labelled G-actin in a 1:1 ratio and actin 
polymerization was induced by the addition of actin polymerization buffer. The subsequent increase 
in fluorescence was measured every minute in a fluorescence spectrophotometer for a total of 55 min 
and data was plotted as Fluorescence (a.u.) against Time (minutes) using Microsoft Excel.
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Figure 19. CAP2 is phosphorylated within the C-terminus and likely occurs within a highly 
conserved consensus sequence. A, in vivo labelling of cells expressing different HA-tagged CAP2 
constructs with 32P ortho-phosphate, demonstrates thatCAP2 is phosphorylated within the C-terminus. 
Labelled cell extracts expressing the empty vector pCI-HA {HA), pCI-HA-CAP2 WT (wild-type), 
pCI-HA-CAP2-C232, pC\-HA-CAP2-N304, or unlabelled wild-type CAP2 (HA-CAP2 COLD) were 
immunoprecipitated using anti-HA (12CA5) conjugated Protein-A beads. Precipitated proteins were 
subjected to SDS-PAGE, transferred to nitrocellulose membrane, and exposed to autoradiographic film 
for five days (32P). Western blot analysis was subsequently performed using Anti-HA antibodies on the 
membrane to confirm the immunoprecipitation of the indicated constructs. Approximate protein 
standard sizes are indicated in kDa. 6, the highly conserved consensus sequence of human CAP2 
that is present within the C-terminus of all CAPs. Residues that are underlined represent those that are 
conserved at greater than 80% in all CAPs. The serines that are highlighted and in bold, represent 
residues that are highly predicted to be phosphorylation sites by the NetPhos 2.0 phosphorylation 
prediction program (out of 1.000). The first serine in grey is conserved in all vertebrate CAPs and has 
score of 0.942, while the white residue is conserved in the majority of all CAPs and has a score of
0.995. The amino acid residue numbers of CAP2 are illustrated next to the amino acids.
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HA-CAP2 which were not labelled with radioactive phosphate, do not appear on the autoradiograph 
(HA-CAP2 COLD). Western analysis reveales that all constructs are immunoprecipitated. Since the 
phosphorylation assays revealed that CAP2 was phosphorylated in the C-terminus, the last 232 amino 
acids of CAP2 were analyzed for any conservation among CAP proteins by performing a Clustal W 
alignment (Hubberstey and Mottillo, 2002), and also searched for consensus phosphorylation sites 
using NetPhos 2.0. A single motif within the C-terminal 232 amino acids of CAP2 was identified. This 
consensus sequence is highly conserved within all CAPs, and contains one serine (S-437) that is 
conserved from yeast to mammals, and a second serine (S-434) conserved in all vertebrates, and both 
are highly predicted to be phosphorylation sites (0.995 and 0.942 out of 1.000; respectively) (Figure 
19B). Thus, it has been revealed that CAP2 is phosphorylated, and a highly conserved consensus 
sequence within the C-terminus where this phosphorylation may occur has been identified.
Discussion
Necabl is a Potential Effector o f CAP2
In order to gain insight into a functional purpose for the Necabl - CAP2 interaction, 
immunoprecipitations were performed that studied the role Ca2+ had on the interaction, and furthermore, 
if Necabl modulated CAP2's binding of actin in any manner. Binding studies demonstrate that when 
CAP2 is bound to Necabl, no actin binding occurs, and that this inhibition is independent of Ca2+. 
Perhaps this is one manner in which CAP2's actin binding is regulated. This role for Necabl may act 
as an additional control for CAP2 during actin dependent processes that occur specifically in neuronal 
cells of the cerebral cortex and hippocampus.
Actin polymerization assays demonstrated that CAP2 is a potent inhibitor of F-actin formation. 
This is in agreement with other CAPs, as yeast and Dictyostelium also inhibits the polymerization of 
actin (Freeman et al., 1995; Gottwald et al., 1996). CAP2 may have a similar function in vivo, as it does 
in vitro; that is to regulate the polymerization of F-actin. This function has been proposed for the 
Drosophila CAP homologue (Baum et al., 2000). The significance of this is that CAP activity would be
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essential in determining when and where actin filaments are formed, and agrees with the idea 
formulated in Chapter Three. This role for CAP has been proposed in Drosophila epithelial cells, where 
it acts to control the apical formation of actin filaments synergistically with the Ableson Tyrosine Kinase 
(Abl) (Baum and Perrimon, 2001).
To further characterize the possible synergistic and/or inhibitory role that Necabl and CAP2 
have on actin dynamics, additional actin polymerization assays were performed. The concomitant 
addition of Necabl and CAP2 in these assays did not differ from that of CAP2. Though this suggests 
that Necabl does not have an effect on CAP2 actin binding in these in vitro assays, this scenario is not 
ruled out in vivo. Reasons for this apparent contradiction exist: the effector role of Necabl may be 
regulated, and a signal that is only apparent in vivo is required; other proteins may be needed to 
manifest this effect of Necabl; the self-association of Necabl may be a preferred state, and would need 
to be alleviated before it binds CAP2; and we are unaware of the kinetics for the Necabl - CAP2 
interaction, as a 1:1 ratio of proteins used in the polymerization assay is not the proper stochiometry 
seen in vivo. We suggest that Necabl acts in vivo as an effector to regulate the actin sequestering 
property of CAP2, and thus its ability to inhibit actin filament formation. A substantial inhibition of actin 
polymerization was also demonstrated by N ecab l We are unaware of any cryptic actin binding motifs 
within Necabl which would explain the inhibition of filament formation. Though, this may explain why 
the ability of Necabl to alleviate CAP2 actin binding was not demonstrated in these assays.
CAP2 May Exist in a Cell Signalling Cascade
In order to understand how CAPs in general may be regulated, in vivo phosphorylation assays 
were performed demonstrating that CAP2 is phosphorylated within the C-terminus. The only other 
known form of CAP regulation has been demonstrated in Dictyostelium, where PIP2 inhibits actin 
binding, and is dependent upon the N-terminus of CAP (Gottwald et al., 1996). In a separate study, 
Benali et al. studied the function of Drosophila CAP by performing overexpression studies in eye disc. 
The disruption of CAP expression in eye disc perturbed the pattern of eye differentiation, while 
overexpression of CAP had no discernable effect, suggesting that CAP is regulated (Benlali et al.,
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2000). Due to the inhibitory role of PIP2 in Dictyostelium, Benali et al. overexpressed the C-terminus 
of CAP in hopes of alleviating the possible inhibition. Surprisingly, no apparent phenotypes were 
observed, suggesting that PIP2 regulation is not conserved within the C-terminus (Benlali et al., 2000), 
and furthermore, that a regulatory domain exists within the C-terminus. This agrees with our analysis 
on the last 232 amino acids of CAP2, wherein a domain that exists within all known CAPs, and is a 
consensus sequence for phosphorylation has been identified.
Serine(S)-434of CAP2 is conserved in all vertebrate CAPs and has a phosphorylation potential 
of 0.942 out of 1.000. Interestingly, S-434 is predicted phosphorylation site for protein kinase C (PKC). 
PKC is a family of phospholipid-dependent serine/threonine kinases, wherein some members are 
calcium dependent due to a C2 domain. PKC is involved in a wide-array of cellular processes, and 
more recently has been implicated in the organization of the actin cytoskeleton (Keenan and Kelleher, 
1998). A role for PKC has also been demonstrated during Ca2+ mediated exocytosis in chromaffin cells. 
In chromaffin cells, the actin cytoskeleton acts as a barrier at the plasma membrane for the release of 
vesicles. PKC, via phosphorylation, was demonstrated to activate a cascade leading to the subsequent 
disassembly of cortical F-actin, and an increase in the release of vesicles (Rose et al., 2001). A PKC 
isoform is also implicated in the outgrowth of neurites. PKCe contains an F-actin binding domain, which 
is crucial for its activation in neurite outgrowth through an unknown upstream signal (Zeidman et al., 
2002). PKC is also implicated in signalling the disassembly of actin stress fibers and the subsequent 
formation of membrane ruffles in smooth muscle cells via the down-regulation of Rho (Brandt et al., 
2002). Interestingly, the identified consensus sequence in CAP2 is just upstream of its actin binding 
motif. Thus, it would be intriguing to propose that phosphorylation of CAP2 by PKC, may regulate its 
actin binding properties.
A second consensus site for phosphorylation, S-437, exists within the C-terminus of CAP2 and 
is highly conserved from yeast to mammals. Only Candida albicans, and Lentinula edodes do not fit 
the pattern, suggesting that they may have lost this possible phosphorylation site during evolution. S- 
438 is also a well conserved serine, though it is not a predicted phosphorylation site. At this site yeast 
S. cerevisiae and S. pombe, and Candida contain a threonine instead of a serine; still constituting a
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residue for phosphorylation. Thus, either of these two residues may be a manner in which CAPs in 
general are regulated. Studies are underway to determine if they do play a role in CAP 
phosphorylation. No current proof exists for CAP involvement in a Rho GTPase family signalling 
cascade, even though it is a common manner in which actin binding proteins are regulated. For 
example, mAbpI, the mammalian homologue of yeast Abp1, which has been shown to interact with 
yeast CAP, acts in a Rac1 signalling cascade (Kessels et al., 2000). Cofilin, which has recently been 
demonstrated to bind human CAP1 (Moriyama and Yahara, 2002), acts through Rho, Rac, and Cdc42 
GTPases (Bamburg et al., 1999; Luo, 2002). Thus, it would be interesting to propose that the CAPs 
also act through the Rho family of GTPase, and these studies are currently underway.
In vivo labelling studies suggest that phosphorylation of CAP2-C232 is higher than that of full- 
length CAP2. This is evident in two instances. Firstly, with the two sets of wild-type CAP2, the level 
of phosphorylation is the same, but the amount immunoprecipitated differs. Secondly the amount of 
CAP2-C232 phosphorylated is substantially higher than wild-type CAP2, even though more CAP2- 
C232 is pulled down. This suggests that a potential regulatory domain of CAP2 phosphorylation exists 
within the N-terminus. All CAPs contain dimerization domains mapped to the N-terminus, and a second 
one within the C-terminus. The N-terminus can also interact with the C-terminus of CAP, suggesting 
that an intramolecular interaction occurs (Hubberstey and Mottillo, 2002). The increased 
phosphorylation observed in CAP2 due to deletion of its N-terminus, is reminiscent of the autoinhibition 
that is observed in Neuronal-Wiscott-Aldrich Syndrome Protein (N-WASP). N-WASP is an activator of 
the ARP2/3 complex, wherein ARP2/3 itself is a weak inducer of actin nucleation and polymerization. 
Binding of N-WASP accelerates the activity of ARP2/3, leading to the de novo nucleation and branching 
of filaments (Prehoda and Lim, 2002). Intramolecular interactions within N-WASP normally block the 
activation region ofthe ARP2/3 complex. Upon cellular stimuli, Cdc42 and PIP2 bind N-WASP, relieving 
the inhibitory conformation, and an active N-WASP can then act upon ARP2/3 (Pufall and Graves, 
2002). Thus, a similar autoinhibition mechanism may exist within CAPs, wherein its autoinhibitory 
conformation prevents phosphorylation within the C-terminus. Likewise, this could regulate actin 
binding, as phosphorylation may result in activating or deactivating this property.
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CHAPTER FIVE 
General Conclusions and Future Studies
This thesis characterizes a novel protein, Neuronal Calcium Binding Protein 1 (Necabl), and 
a role for the human CAPs in neuronal function. Results demonstrated that Necabl is preferentially 
expressed in brain, specifically in the regions ofthe cerebral cortex and hippocampus where CAP2 is 
also present at high levels. Immunoprecipitation studies in addition to two-hybrid analysis, 
demonstrated that Necabl is capable of dimerizing independent of calcium. Immunolocalization studies 
revealed that both Necabl and CAP2 co-localize to neurite processes. Furthermore, CAP2 is potent 
inhibitor of actin polymerization in vitro, and does not co-localize with F-actin in neurons. 
Immunoprecipitation studies demonstrated that Necabl may be an effector of CAP2. Additionally, the 
following statements can be concluded that were initially proposed in the Thesis Objectives:
1. Necabl is a novel binding partner ofthe human CAPs.
2. Necabl and CAP2 are physiological binding partners that interact via coiled-coils and 
Necabl is a potential SNARE effector.
3. CAP2 and Necabl are cytosolic proteins which also display a membrane localization.
4. Necabl functions to prevent CAP2 actin binding, and CAP2 is regulated at the level of 
phosphorylation.
Therefore, results presented in this thesis put forth the notion of a neuronal role for CAP2 and Necabl.
The Cyclase Associated Proteins, are highly conserved actin binding proteins that are thought 
to link rearrangements in the actin cytoskeleton to cellular signalling events, as is evident with yeast 
CAP. A role for CAPs is also evident in vesicle trafficking; CAP mutants in both yeast and Dictyostelium 
are deficient for endocytosis (Noegel et al., 1999; Wesp et al., 1997). Furthermore, yeast SNC1, a 
homologue ofthe neuronal v-SNARE synaptobrevin, complements deletions associated with the C- 
terminus of yeast CAP (Gerst et al., 1992). Finally, yeast CAP interacts with a multitude of proteins 
involved in endocytosis such as Abp1, Rvs167, and Slalp (Drees et al., 2001).
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The exact nature of CAPs function during vesicle trafficking still remains uncertain, but a 
general functional role for CAPs in regulating the actin cytoskeleton is evident. Research in a wide 
array of organisms poses a role for CAPs as determinants in actin filament formation. Study of 
Drosophila CAP reveals that it inhibits the polymerization of actin and regulates cell polarity, and a 
similar role was also demonstrated in yeast (Baum et al., 2000). Furthermore, Drosophila CAP limits 
the spatial formation of actin filaments in epithelial cells (Baum and Perrimon, 2001), and in a separate 
study, acts to prevent actin filament formation during the cell shape changes in eye discs (Benlali et al., 
2000). Similarly, overexpression of Arabidopsis CAP in suspension-cultured tobacco cells, resulted 
in the loss of actin filaments (Barrero et al., 2002). Thus, human CAPs may have analogous roles 
during vesicle trafficking and neuronal plasticity; that is, determining when and where actin filaments 
are formed during the dynamics of these processes. We have focussed our attention on characterizing 
the function ofthe human CAPs and their role in neuronal processes.
The involvement ofthe actin cytoskeleton in neuronal processes is strikingly apparent, though 
many ofthe actual molecular players involved still remain elusive. The actin cytoskeleton has an active 
role during synaptic transmission in regulating the pool of reserve vesicles (Doussau and Augustine, 
2000), and also the actual release of neurotransmitter, where it acts to restrict the fusion of vesicles 
(Doussau et al., 2000; Humeau et al., 2002; Morales et al., 2000). Furthermore, actin has been 
implicated in recycling synaptic vesicles, where filaments are thought to propel endocytosed vesicles 
back to the releasable pool (Shupliakov et al., 2002).
Studies have also identified actin as the ideal candidate for the morphological changes that 
occur during synaptic plasticity. These changes occur in excitatory neurons during long term 
potentiation (LTP). Specifically, actin dynamics are essential to LTP as F-actin depolymerization drugs 
in hippocampal neurons impaired its induction and maintenance (Krucker et al., 2000). Furthermore, 
the disruption of F-actin in young hippocampal neurons, completely inhibited the formation of dendritic 
spines, while no effect was observed on mature neurons, thereby suggesting that dynamic actin is 
needed for spine formation, and a stable actin cytoskeleton for the maintenance of mature synapses 
(Zhang and Benson, 2001). Areal-time view of actin-mediated morphological changes was observed
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during LTP, as its induction resulted in the remodelling of both pre- and postsynaptic actin of 
hippocampal neurons. In addition, these actin dependent changes resulted in the formation of new 
active synapses, capable of forming synaptic connections (Colicos et al., 2001). Thus, it is evident that 
the dynamics ofthe actin cytoskeleton are essential to neuronal function.
Future Experiments
The SNAREs involved in synaptic transmission can be regulated in different manners, such 
as through the Rab GTPase Rab3a, the syntaxin 1a effector nSed, and through the phosphorylation 
of kinases such as CaMKII, PKA, and PKC (Lin and Scheller, 2000). The interaction of Necabl with 
syntaxin 1 and the homology of its central coiled-coil to an R-SNARE motif, suggests that it may be an 
effector ofthe neuronal SNARE complex. Necabl is unlikely to be a true SNARE protein, as it lacks 
a transmembrane domain, and its cellular localization is mainly cytosolic. In accordance, Necabl would 
not be able to directly mediate fusion in any type of SNARE complex, as its R-SNARE would displace 
that of synaptobrevin (in agreement with the 3Q:1R SNARE model), and disrupt the prerequisite for a 
minimum of two transmembrane bound SNAREs during vesicle fusion (Scales et al., 2002). This is 
further proof that Necabl's role is an effector of the neuronal SNAREs, rather than a true SNARE itself.
NecabTs calcium binding properties in addition to its restricted expression in pyramidal 
neurons of layer 4 of cerebral cortex, and the CA2 region of the hippocampus (Sugita et al., 2002), 
suggests a function during LTP. LTP mechanistically occurs when the neurotransmitter glutamate is 
released from the presynapse and binds glutamatergic receptors AMPA and NMDA (Malenka and 
Nicoll, 1999). AMPA receptors provide inward current of ions during low periods of stimulation. Linder 
strong periods of stimulation the postsynaptic neuron is depolarized, activating the voltage-dependent 
NMDA receptors which causes an influx of Ca2+ ions into the dendritic spine. This rise of intracellular 
Ca2+is the actual trigger for LTP; activating different signal transduction molecules such as CaMKII and 
PKC, which carry out the actual molecular functions (Malenka and Nicoll, 1999). Thus, Necabl may 
respond to the rise of intracellular Ca2+, and modulate some function of the exocytic process in either 
the pre- or postsynapse.
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To further understand a role for Necabl in synaptic transmission and plasticity, additional 
studies are required. Understanding the stochiometry of NecabTs Ca2+ binding will be essential to 
understanding its function, especially if it acts in response to the influx of Ca2+during LTP. For example, 
the Synaptotagmins have different Ca2+ binding affinities attributed to specific functions (Sudhof, 2002). 
The possibility that Necabl through its R-SNARE, acts as a mediator of SNARE complex formation, 
could be verified through competitive bindings. Additionally, x-ray crystallography would deduce the 
structure of Necabl, fortifying its ability to associate with SNAREs, since their structures are already 
known. Furthermore, cracked-cell assays would elucidate a functional role for Necabl in exocytosis, 
in which recombinant Necabl is introduced into PC12 cells, and the subsequent release of 
norepinephrine is measured. This protocol has been used regularly to study either the inhibitory or 
stimulatory effect that a protein has on Ca2+mediated neurotransmitter release (Earles et al., 2001; Shin 
et al., 2002). NecabTs localization within the pre and/or postsynapse would strengthen a role in 
synaptic plasticity. Once verified, functional studies of overexpressing Necabl, or the introduction of 
Necabl antibodies in hippocampal neurons could elucidated a role in LTP. Understanding how Necabl 
is regulated will also be pertinent to elucidating its function. For example, determining if Necabl is 
phosphorylated, via in vivo phosphorylation assays and subsequent phospho-amino analysis, and 
deducing which kinase, could shed light on its role. Verifying that Necabl is a signal responsive 
molecule could provide a link between extracellular signalling events (i.e. those during LTP) and the 
SNARE-dependent exocytic machinery, as the mechanisms are currently poorly understood. Also, 
determining what purpose Necabl dimerization serves will be important in understanding its function.
Similar to Necabl, we have determined CAP2 to be differentially expressed in the brain, 
exhibiting highest levels in the cortex and hippocampus, which suggests a specialized role in these 
regions. Firstly, this implies that Necabl and CAP2 may have similar functions in these regions. 
Secondly, CAP2 has a more specified role than a ubiquitous actin sequestering protein. CAP2's 
multiple interaction domains, in addition to being phosphorylated, provides a manner that CAPs in 
general could respond to extracellular signals and impart an effect on the actin cytoskeleton. This is 
in contrastto the ubiquitous G-actin sequestering protein (3-thymosin, which does not have any protein-
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protein interaction domains, nor has any active role in filament assembly/disassembly (Pollard et al., 
2000).
The role for CAP2 that we propose would be similar to that of the actin regulatory protein N- 
WASP. N-WASP integrates cell signalling events through PIP2 and Cdc42, activating the ARP2/3 
complex to form de novo polymerization of actin filaments, and thus resulting in actin-dependent 
morphological changes in a cell (Prehoda and Lim, 2002). In Chapter Four, it was hypothesized that 
CAP2's regulation occurred through an autoinhibitory mechanism, equivalent to that of N-WASP, 
indicating another similarity, and further confirmation that CAP2 may respond to cell signalling events. 
Furthermore, WASP auto-inhibition is relieved and thus activated upon phosphorylation (Cory et al., 
2002). Therefore, through phosphorylation, CAP2 may be regulated in a similar manner. Determining 
the kinase that phosphorylates CAP2 will be imperative to further understanding its function. As 
mentioned in Chapter Four, PKC is a good candidate for this kinase. In addition to its effects on the 
actin cytoskeleton, PKC also has a role in synaptic plasticity. Inhibitors of PKC block LTP and 
increased activity of PKC enhances synaptic transmission (Malenka and Nicoll, 1999). This, in addition 
to Necabl's putative role discussed above, poses the interesting possibility that CAP2 may also have 
a role in synaptic plasticity.
It is apparent that the morphological changes during synaptic plasticity are dependent on the 
actin cytoskeleton and an important regulator of actin dependent changes within the brain is LIMK1. 
It exerts its effects by phosphorylating and inactivating cofilin, thus inhibiting the subsequent turnover 
of actin filaments. The importance of this relationship is evident in LIMK1 knockout mice, which exhibit 
abnormalities in dendritic spine morphology, synaptic transmission, fear responses, spatial learning, 
and enhanced LTP (Meng et al., 2002). These phenotypes are a direct result of a hyperactive cofilin 
and an abnormal actin cytoskeleton. Interestingly, human CAP1 has been recently implicated in playing 
a co-operative role with cofilin in the turnover of actin filaments. The interaction between cofilin and 
CAP1 is dependent on actin and similar results were reported with human CAP2 (Moriyama and 
Yahara, 2002). Thus, this provides further evidence that the human CAPs may play a role in the actin- 
dependent morphological changes during synaptic transmission and plasticity. It was proposed that
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Necabl acts to inhibitCAP2 actin binding, in addition, Necabl may also preventthe interaction between 
hCAPs and cofilin, and thus the role in actin filament turnover.
The recent paper that identified the association between CAP1 and cofilin, proposed that it 
serves to accelerate the turnover of actin filaments via CAPTs ability to recycle cofilin and actin 
(Moriyama and Yahara, 2002). The in vivo function for cofilin in treadmilling of actin filaments through 
its ability to sever filaments and bind G-actin is well accepted, and clearly evident in overexpression 
studies which demonstrate the formation of cofilin actin rods/bundles (Minamide et al., 2000; Pfannstiel 
et al., 2001). This is in contrast to overexpression studies with Arabidopsis CAP which revealed 
reduced F-actin filaments and mitosis defects (Barrero et al., 2002); in our own studies, overexpression 
of CAP2-GFP in mammalian cells via a recombinant adenoviral vector, demonstrated severed actin 
filaments and also a reduced mitotic activity (Mottillo et al., American Society for Cell Biology Poster 
Presentation, 2001). Thus, these results dispel the idea that CAPs have an active role in filament 
formation, but rather, agree with our premise that CAPs act negatively to regulate the formation of F- 
actin filaments. We do not dismiss the interaction between cofilin and the human CAPs; but 
alternatively suggest that CAPs act to regulate the availability of monomers to proteins that rearrange 
or assemble F-actin structures. Thus, determining the spatial and temporal formation of actin filaments. 
This idea is further supported by immunofluorescence studies in Chapter Three, where CAP2 and F- 
actin did not co-localize. Furthermore, the ability of hCAPs to recycle actin (i.e. exchange ADP for ATP) 
(Moriyama and Yahara, 2002) would nonetheless fit in with our model, as this would be a fundamental 
function of CAPs if they are to limit F-actin formation and aid in the subsequent delivery of monomers.
CAP2's role in neurite extensions discussed in Chapter Three, in addition to the current idea 
that CAP2 functions during synaptic plasticity, puts forth the idea that CAP2 has a general role in 
regulating actin dynamics during neuronal function. The putative role in neurite outgrowth can be 
assimilated to the role that CAPs play in cell elongation, suggested in cotton (Kawai et al., 1998), 
Drosophila (Benlali et al., 2000), and Arabidopsis (Barrero et al., 2002), and hyphal formation in 
Candida albicans (Bahn and Sundstrom, 2001). Furthermore, similar mechanisms have been 
suggested during bud formation in yeast and neuritogenesis in vertebrates (da Silva and Dotti, 2002).
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Interestingly, yeast deficient for cap undergo abnormal cell budding (Fedor-Chaiken et al., 1990; Field 
et al., 1990), is further suggestive of a plausible role in neurite extension. This premise also has 
implications during neuronal rewiring, as the retraction of synapses and neurites is an actin-dependent 
process (Luo, 2002) and CAP2 could be involved in this. In accordance with its functional role in the 
brain, CAP2 would be responsive to signalling cascades involving neurite extensions and synaptic 
plasticity, in which we have proposed that PKC may be one manner of eliciting this signal. In 
accordance with our suggested neuronal role for hCAPs and their ability to respond to neuronal 
signalling, Drosophila CAP has been recently demonstrated to be responsive to axon guidance 
signalling via the Slit/Robo repulsive signal. This function of CAP occurred in collaboration with the 
tyrosine kinase Abl (Wills et al., 2002). A general role for both Necabl and CAP2 in neuronal function 
is further supported by the observation that both are only present in vertebrates, organisms in which 
the neuronal system is most developed and advanced.
Studies that merit further examination of CAP2 include its manner of regulation, in which we 
have proposed an autoinhibitory mechanism and also phosphorylation. Determining domains 
necessary for CAP2 autoinhibition can be elucidated by deletion mutant analysis combined with activity 
assays (i.e. actin binding). One such domain that merits examination is the RLE motif (i.e. dimerization 
domain) that has already been mutated. Additionally, PKC was suggested as a candidate for CAP2 
phosphorylation, in vitro phosphorylation assays would determine if PKC is indeed the kinase that 
phosphorylates CAP2. Also performing site directed mutagenesis on the conserved serine residues 
within the C-terminus of CAP2 (S-434, S-437, S-438) and subsequent in vivo labelling studies will 
determine if either of these sites are phosphorylated. Overexpression studies in hippocampal neurons 
and cracked-cell assays as those suggested for Necabl, would also verify a role for human CAPs in 
both neurotransmitter release and synaptic plasticity. Developing a dominant negative form of CAP2 
with respect to actin binding, along with overexpression studies, would allow elucidation of its function. 
This dominant negative form may exist in CAP2 phosphorylation, thus making mutants that act as either 
pseudophosphorylated (i.e. S to E), or nonphosphorylatable (i.e. S to A), accompanied by 
overexpression studies will prove essential in further understanding human CAP function.
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Understanding the signalling pathway(s) that act upon CAP2 will also be essential to further determining 
its role. In vivo phosphorylation assays in conjunction with growth factortreatmentcould elucidate such 
signalling cascades. For example, determining if CAP2 phosphorylation changes in response to PDGF 
(Rac pathway), bradykinin (Cdc42 pathway), or PMA (PKC and Rac pathway). Further studies that look 
at the role that Necabl plays in the interaction between CAP2 and cofilin merits research, and can be 
elucidated through competitive binding studies. Also, characterization ofthe mammalian role that Abl 
has in CAP function will need to be verified.
In conclusion, this study suggests that CAP2 is a regulator of actin filament formation, likely 
responding to neuronal signalling events to determine when and where actin filaments are formed. It 
is proposed that CAPs are regulatory molecules that function to control actin polymerization, and the 
dynamics ofthe actin cytoskeleton in response to extracellular signals. The functional link between 
CAP2 and Necabl may be dependent on the morphological and functional changes that occur during 
synaptic plasticity. Studies are currently underway to determine the specific functional roles that 
Necabl, CAP2 and actin play in neuronal plasticity and actin reorganization.
106
Reproduced with permission o fthe copyright owner. Further reproduction prohibited without permission.
References:
Altschuler, Y., Barbas, S.M., Terlecky, L.J., Tang, K., Hardy, S., Mostov, K.E. and Schmid, S.L.
(1998) Redundant and distinct functions for dynamin-1 and dynamin-2 isoforms. J Cell Biol, 143, 
1871-81.
Augustine, G.J. (2001) How does calcium trigger neurotransmitter release? Curr Opin Neurobiol, 
11,320-6.
Bahn, Y.S. and Sundstrom, P. (2001) CAP1, an adenylate cyclase-associated protein gene, 
regulates bud-hypha transitions, filamentous growth, and cyclic AMP levels and is required for 
virulence of Candida albicans. JBacteriol, 183,3211-23.
Bamburg, J.R. (1999) Proteins ofthe ADF/cofilin family: essential regulators of actin dynamics. 
Annu Rev Cell Dev Biol, 15,185-230.
Bamburg, J.R., McGough, A. and Ono, S. (1999) Putting a new twist on actin: ADF/cofilins modulate 
actin dynamics. Trends Cell Biol, 9,364-70.
Barrero, R.A., Umeda, M., Yamamura, S. and Uchimiya, H. (2002) Arabidopsis CAP regulates the 
actin cytoskeleton necessary for plant cell elongation and division. Plant Cell, 14,149-63.
Baum, B., Li, W. and Perrimon, N. (2000) A cyclase-associated protein regulates actin and cell 
polarity during Drosophila oogenesis and in yeast. Curr Biol, 10, 964-73.
Baum, B. and Perrimon, N. (2001) Spatial control ofthe actin cytoskeleton in Drosophila epithelial 
cells. Nat Cell Biol, 3 ,883-90.
Benlali, A., Draskovic, I., Hazelett, D.J. and Treisman, J.E. (2000) act up controls actin 
polymerization to alter cell shape and restrict Hedgehog signaling in the Drosophila eye disc. Cell, 
101,271-81.
Bernier, G., Vukovich, W., Neidhardt, L., Herrmann, B.G. and Gruss, P. (2001) Isolation and 
characterization of a downstream target of Pax6 in the mammalian retinal primordium.
Development, 128,3987-94.
Bernstein, B.W., Painter, W.B., Chen, H., Minamide, L.S., Abe, H. and Bamburg, J.R. (2000) 
Intracellular pH modulation of ADF/cofilin proteins. Cell Motil Cytoskeleton, 47,319-36.
Borgdorff, A.J. and Choquet, D. (2002) Regulation of AMPA receptor lateral movements. Nature, 
417, 649-53.
Brandt, D., Gimona, M., Hillmann, M., Haller, H. and Mischak, H. (2002) Protein kinase C induces 
actin reorganization via a Src- and Rho- dependent pathway. J Biol Chem, 277,20903-10.
107
Reproduced with permission o fthe copyright owner. Further reproduction prohibited without permission.
Brunger, A.T. (2000) Structural insights into the molecular mechanism of Ca(2+)-dependent 
exocytosis. CurrOpin Neurobiol, 10,293-302.
Burkhard, P., Stetefeld, J. and Strelkov, S.V. (2001) Coiled coils: a highly versatile protein folding 
motif. Trends Cell Biol, 11,82-8.
Caillard, O., Moreno, H., Schwaller, B., Llano, I., Celio, M.R. and Marty, A. (2000) Role ofthe 
calcium-binding protein parvalbumin in short-term synaptic plasticity. Proc Natl Acad Sci USA,  97, 
13372-7.
Carlier, M.F. and Pantaloni, D. (1997) Control of actin dynamics in cell motility. J Mol Biol, 269,459- 
67.
Chapman, E.R., An, S., Edwardson, J.M. and Jahn, R. (1996) A novel function for the second C2 
domain of synaptotagmin. Ca2+- triggered dimerization. J Biol Chem, 271, 5844-9.
Chavrier, P. and Goud, B. (1999) The role of ARF and Rab GTPases in membrane transport. Curr 
Opin Cell Biol, 11,466-75.
Chen, D., Minger, S.L., Honer, W.G. and Whiteheart, S.W. (1999) Organization ofthe secretory 
machinery in the rodent brain: distribution ofthe t-SNAREs, SNAP-25 and SNAP-23. Brain Res, 
831,11-24.
Chin, L.S., Nugent, R.D., Raynor, M.C., Vavalle, J.P. and Li, L. (2000) SNIP, a novel SNAP-25- 
interacting protein implicated in regulated exocytosis. J Biol Chem, 275,1191-200.
Colicos, M.A., Collins, B E., Sailor, M.J. and Goda, Y. (2001) Remodeling of synaptic actin induced 
by photoconductive stimulation. Cell, 107,605-16.
Cory, G.O., Garg, R., Cramer, R. and Ridley, A.J. (2002) Phosphorylation of Tyrosine 291 
Enhances the Ability of WASp to Stimulate Actin Polymerization and Filopodium Formation. J Biol 
Chem, 277,45115-45121.
da Silva, J.S. and Dotti, C.G. (2002) Breaking the neuronal sphere: regulation ofthe actin 
cytoskeleton in neuritogenesis. Nat Rev Neurosci, 3,694-704.
Daly, C. and Ziff, E.B. (1997) Post-transcriptional regulation of synaptic vesicle protein expression 
and the developmental control of synaptic vesicle formation. J Neurosci, 17,2365-75.
Doussau, F. and Augustine, G.J. (2000) The actin cytoskeleton and neurotransmitter release: an 
overview. Biochimie, 82, 353-63.
Doussau, F., Gasman, S., Humeau, Y., Vitiello, F., Popoff, M., Boquet, P., Bader, M.F. and Poulain, 
B. (2000) A Rho-related GTPase is involved in Ca(2+)-dependent neurotransmitter exocytosis. J  
Biol Chem, 275, 7764-70.
108
Reproduced with permission o fthe copyright owner. Further reproduction prohibited without permission.
Drees, B.L., Sundin, B., Brazeau, E., Caviston, J.P., Chen, G.C., Guo, W., Kozminski, K.G., Lau, 
M.W., Moskow, J.J., Tong, A., Schenkman, L.R., McKenzie, A., 3rd, Brennwald, P., Longtine, M„ Bi,
E., Chan, C., Novick, P., Boone, C., Pringle, J.R., Davis, T.N., Fields, S. and Drubin, D.G. (2001) A 
protein interaction map for cell polarity development. J Cell Biol, 154, 549-71.
Earles, C.A., Bai, J., Wang, P. and Chapman, E.R. (2001) The tandem C2 domains of 
synaptotagmin contain redundant Ca2+ binding sites that cooperate to engage t-SNAREs and 
trigger exocytosis. J Cell Biol, 154,1117-23.
Ellis, S. and Mellor, H. (2000) Regulation of endocytic traffic by rho family GTPases. Trends Cell 
Biol, 10,85-8.
Fasshauer, D., Sutton, R.B., Brunger, A.T. and Jahn, R. (1998) Conserved structural features ofthe 
synaptic fusion complex: SNARE proteins reclassified as Q- and R-SNAREs. Proc Natl Acad Sci U 
SA, 95,15781-6.
Fedor-Chaiken, M., Deschenes, R.J. and Broach, J.R. (1990) SRV2, a gene required for RAS 
activation of adenylate cyclase in yeast. Cell, 61,329-40.
Field, J., Vojtek, A., Ballester, R., Bolger, G., Colicelli, J., Ferguson, K., Gerst, J., Kataoka, T., 
Michaeli, T., Powers, S. and et al. (1990) Cloning and characterization of CAP, the S. cerevisiae 
gene encoding the 70 kd adenylyl cyclase-associated protein. Cell, 61,319-27.
Freeman, N.L., Chen, Z., Horenstein, J., Weber, A. and Field, J. (1995) An actin monomer binding 
activity localizes to the carboxyl-terminal half of the Saccharomyces cerevisiae cyclase-associated 
protein. J Biol Chem, 270,5680-5.
Freeman, N.L., Lila, T., Mintzer, K.A., Chen, Z., Pahk, A.J., Ren, R., Drubin, D.G. and Field, J.
(1996) A conserved proline-rich region ofthe Saccharomyces cerevisiae cyclase-associated 
protein binds SH3 domains and modulates cytoskeletal localization. Mol Cell Biol, 16,548-56.
Fukuda, M., Ogata, Y., Saegusa, C., Kanno, E. and Mikoshiba, K. (2002) Alternative splicing 
isoforms of synaptotagmin VII in the mouse, rat and human. Biochem J, 365,173-80.
Geli, M.l. and Riezman, FI. (1998) Endocytic internalization in yeast and animal cells: similar and 
different. J Cell Sci, 111,1031-7.
Gerst, J.E., Ferguson, K., Vojtek, A., Wigler, M. and Field, J. (1991) CAP is a bifunctional 
component of the Saccharomyces cerevisiae adenylyl cyclase complex. Mol Cell Biol, 11,1248-57.
Gerst, J.E., Rodgers, L., Riggs, M. and Wigler, M. (1992) SNC1, a yeast homolog ofthe synaptic 
vesicle-associated membrane protein/synaptobrevin gene family: genetic interactions with the RAS 
and CAP genes. Proc Natl Acad Sci USA,  89,4338-42.
Gieselmann, R. and Mann, K. (1992) ASP-56, a new actin sequestering protein from pig platelets
109
Reproduced with permission o fthe copyright owner. Further reproduction prohibited without permission.
with homology to CAP, an adenylate cyclase-associated protein from yeast. FEBSLett, 298,149- 
53.
Gottwald, U., Brokamp, R., Karakesisoglou, I., Schleicher, M. and Noegel, A.A. (1996) Identification 
of a cyclase-associated protein (CAP) homologue in Dictyostelium discoideum and characterization 
of its interaction with actin. Mol Biol Cell, 7,261-72.
Greene, L.A. and Tischler, A.S. (1976) Establishment of a noradrenergic clonal line of rat adrenal 
pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci USA,  73, 
2424-8.
Hall, A. (1998) Rho GTPases and the actin cytoskeleton. Science, 279,509-14.
Hof, P.R., Glezer, II, Conde, F., Flagg, R.A., Rubin, M.B., Nimchinsky, E.A. and Vogt Weisenhorn,
D.M. (1999) Cellular distribution ofthe calcium-binding proteins parvalbumin, calbindin, and 
calretinin in the neocortex of mammals: phylogenetic and developmental patterns. J Chem 
Neuroanat, 16, 77-116.
Hubberstey, A., Yu, G., Loewith, R., Lakusta, C. and Young, D. (1996) Mammalian CAP interacts 
with CAP, CAP2, and actin. J Cell Biochem, 61,459-66.
Hubberstey, A.V. and Mottillo, E.P. (2002) Cyclase-associated proteins: CAPacityfor linking signal 
transduction and actin polymerization. Faseb J, 16,487-99.
Humeau, Y., Popoff, M.R., Kojima, H., Doussau, F. and Poulain, B. (2002) Rac GTPase Plays an 
Essential Role in Exocytosis by Controlling the Fusion Competence of Release Sites. J Neurosci, 
22, 7968-81.
Jahn, R. and Sudhof, T.C. (1999) Membrane fusion and exocytosis. Annu Rev Biochem, 68,863- 
911.
Kawai, M., Aotsuka, S. and Uchimiya, H. (1998) Isolation of a cotton CAP gene: a homologue of 
adenylyl cyclase-associated protein highly expressed during fiber elongation. Plant Cell Physiol, 39, 
1380-3.
Keenan, C. and Kelleher, D. (1998) Protein kinase C and the cytoskeleton. Cell Signal, 10, 225-32.
Kessels, M.M., Engqvist-Goldstein, A.E. and Drubin, D.G. (2000) Association of mouse actin- 
binding protein 1 (mAbp1/SH3P7), an Src kinase target, with dynamic regions ofthe cortical actin 
cytoskeleton in response to Rac1 activation. Mol Biol Cell, 11, 393-412.
Kessels, M.M., Engqvist-Goldstein, A.E., Drubin, D.G. and Qualmann, B. (2001) Mammalian Abp1, 
a signal-responsive F-actin-binding protein, links the actin cytoskeleton to endocytosis via the 
GTPase dynamin. J Cell Biol, 153, 351-66.
110
Reproduced with permission o fthe copyright owner. Further reproduction prohibited without permission.
KhosrowShahian, F., Hubberstey, A.V. and Crawford, M.J. (2002) CAP1 expression is 
developmental^ regulated in Xenopus. Mech Dev, 113,211-4.
Krucker, T., Siggins, G.R. and Halpain, S. (2000) Dynamic actin filaments are required for stable 
long-term potentiation (LTP) in area CA1 ofthe hippocampus. Proc Natl Acad Sci USA,  97,6856- 
61.
Kuhn, T.B., Meberg, P.J., Brown, M.D., Bernstein, B.W., Minamide, L.S., Jensen, J.R., Okada, K., 
Soda, E.A. and Bamburg, J.R. (2000) Regulating actin dynamics in neuronal growth cones by 
ADF/cofilin and rho family GTPases. JNeurobiol, 44,126-44.
Lai, M.M., Hong, J.J., Ruggiero, A.M., Burnett, P.E., Slepnev, V.I., De Camilli, P. and Snyder, S.H. 
(1999) The calcineurin-dynamin 1 complex as a calcium sensor for synaptic vesicle endocytosis. J 
Biol Chem, 274,25963-6.
Lee, D.S., Tomita, S., Kirino, Y. and Suzuki, T. (2000) Regulation of X11 L-dependent amyloid 
precursor protein metabolism by XB51, a novel X11 L-binding protein. J Biol Chem, 275,23134-8. 
Lewit-Bentley, A. and Rety, S. (2000) EF-hand calcium-binding proteins. CurrOpin Struct Biol, 10, 
637-43.
Li, Y., Chin, L.S., Weigel, C. and Li, L. (2001) Spring, a novel RING finger protein that regulates 
synaptic vesicle exocytosis. J Biol Chem, 276,40824-33.
Lila, T. and Drubin, D.G. (1997) Evidence for physical and functional interactions among two 
Saccharomyces cerevisiae SH3 domain proteins, an adenylyl cyclase-associated protein and the 
actin cytoskeleton. Mol Biol Cell, 8,367-85.
Lin, R.C. and Scheller, R.H. (2000) Mechanisms of synaptic vesicle exocytosis. Annu Rev Cell Dev 
Biol, 16,19-49.
Lledo, P.M., Zhang, X., Sudhof, T.C., Malenka, R.C. and Nicoll, R.A. (1998) Postsynaptic membrane 
fusion and long-term potentiation. Science, 279,399-403.
Lombardi, R. and Riezman, H. (2001) Rvs161p and Rvs167p, the two yeast amphiphysin 
homologs, function together in vivo. J Biol Chem, 276, 6016-22.
Lu, W., Man, H., Ju, W., Trimble, W.S., MacDonald, J.F. and Wang, Y.T. (2001) Activation of 
synaptic NMDA receptors induces membrane insertion of new AMPA receptors and LTP in cultured 
hippocampal neurons. Neuron, 29, 243-54.
Luo, L. (2002) Actin Cytoskeleton Regulation in Neuronal Morphogenesis and Structural Plasticity. 
Annu Rev Cell Dev Biol, 3, 3.
Maciver, S.K. and Hussey, P.J. (2002) The ADF/cofilin family: actin-remodeling proteins. Genome 
Biol, 3, reviews3007.
111
Reproduced with permission o fthe copyright owner. Further reproduction prohibited without permission.
Malenka, R.C. and Nicoll, R.A. (1999) Long-term potentiation—a decade of progress? Science, 285, 
1870-4.
Matozaki, T., Nakanishi, H. and Takai, Y. (2000) Small G-protein networks: their crosstalk and 
signal cascades. Cell Signal, 12,515-24.
Mayer, B.J. (2001) SH3 domains: complexity in moderation. J Cell Sci, 114,1253-63.
McPherson, P.S. (1999) Regulatory role of SH3 domain-mediated protein-protein interactions in 
synaptic vesicle endocytosis. Cell Signal, 11,229-38.
McPherson, P.S. (2002) The endocytic machinery at an interface with the actin cytoskeleton: a 
dynamic, hip intersection. Trends Cell Biol, 12,312-5.
Meng, Y., Zhang, Y., Tregoubov, V., Janus, C., Cruz, L., Jackson, M., Lu, W.Y., MacDonald, J.F., 
Wang, J.Y., Falls, D.L. and Jia, Z. (2002) Abnormal spine morphology and enhanced LTP in LIMK-1 
knockout mice. Neuron, 35,121-33.
Minamide, L.S., Striegl, A.M., Boyle, J.A., Meberg, P.J. and Bamburg, J.R. (2000) 
Neurodegenerative stimuli induce persistent ADF/cofilin-actin rods that disrupt distal neurite 
function. Nat Cell Biol, 2 ,628-36.
Morales, M., Colicos, M.A. and Goda, Y. (2000) Actin-dependent regulation of neurotransmitter 
release at central synapses. Neuron, 2 7 ,539-50.
Moriyama, K. and Yahara, I. (2002) Human CAP1 is a key factor in the recycling of cofilin and actin 
for rapid actin turnover. J Cell Sci, 115,1591 -601.
Munn, A.L. (2001) Molecular requirements for the internalisation step of endocytosis: insights from 
yeast. Biochim Biophys Acta, 1535,236-57.
Munn, A.L., Stevenson, B.J., Geli, M.l. and Riezman, H. (1995) end5, end6, and end7: mutations 
that cause actin delocalization and block the internalization step of endocytosis in Saccharomyces 
cerevisiae. Mol Biol Cell, 6,1721-42.
Nakayama, A.Y., Harms, M.B. and Luo, L. (2000) Small GTPases Rac and Rho in the maintenance 
of dendritic spines and branches in hippocampal pyramidal neurons. J Neurosci, 20,5329-38.
Nikolic, M. (2002) The role of Rho GTPases and associated kinases in regulating neurite outgrowth. 
Int J Biochem Cell Biol, 34,731-45.
Nishida, Y., Shima, F., Sen, H., Tanaka, Y., Yanagihara, C., Yamawaki-Kataoka, Y., Kariya, K. and 
Kataoka, T. (1998) Coiled-coil interaction of N-terminal 36 residues of cyclase-associated protein 
with adenylyl cyclase is sufficient for its function in Saccharomyces cerevisiae ras pathway. J Biol 
Chem, 273, 28019-24.
112
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Noegel, A.A., Rivero, F., Albrecht, R., Janssen, K.P., Kohler, J., Parent, C.A. and Schleicher, M.
(1999) Assessing the role of the ASP56/CAP homologue of Dictyostelium discoideum and the 
requirements for subcellular localization. J Cell Sci, 112,3195-203.
Patel, B.N. and Van Vactor, D.L. (2002) Axon guidance: the cytoplasmic tail. CurrOpin Cell Biol, 14, 
221-9.
Pfannstiel, J., Cyrklaff, M., Habermann, A., Stoeva, S., Griffiths, G., Shoeman, R. and Faulstich, H. 
(2001) Human cofilin forms oligomers exhibiting actin bundling activity. J Biol Chem, 276,49476-84.
Pollard, T.D., Blanchoin, L. and Mullins, R.D. (2000) Molecular mechanisms controlling actin 
filament dynamics in nonmuscle cells. Annu RevBiophys Biomol Struct, 29,545-76.
Portnoy, D.A., Auerbuch, V. and Glomski, I.J. (2002) The cell biology of Listeria monocytogenes 
infection: the intersection of bacterial pathogenesis and cell-mediated immunity. J Cell Biol, 158, 
409-14.
Prehoda, K.E. and Lim, W.A. (2002) How signaling proteins integrate multiple inputs: a comparison 
of N-WASP and Cdk2. CurrOpin Cell Biol, 14,149-54.
Pufall, M.A. and Graves, B.J. (2002) AUTOINHIBITORY DOMAINS: Modular Effectors of Cellular 
Regulation. Annu Rev Cell Dev Biol, 18,421-62.
Qualmann, B., Kessels, M.M. and Kelly, R.B. (2000) Molecular links between endocytosis and the 
actin cytoskeleton. J Cell Biol, 150, F111 -6.
Rao, A. and Craig, A.M. (2000) Signaling between the actin cytoskeleton and the postsynaptic 
density of dendritic spines. Hippocampus, 10,527-41.
Robinson, M.S., Watts, C. and Zerial, M. (1996) Membrane dynamics in endocytosis. Cell, 84,13- 
21 .
Rose, S.D., Lejen, T., Zhang, L. and Trifaro, J.M. (2001) Chromaffin cell F-actin disassembly and 
potentiation of catecholamine release in response to protein kinase C activation by phorbol esters is 
mediated through myristoylated alanine-rich C kinase substrate phosphorylation. J Biol Chem, 276, 
36757-63.
Scales, S.J., Hesser, B.A., Masuda, E.S. and Scheller, R.H. (2002) Amisyn, a Novel Syntaxin- 
binding Protein That May Regulate SNARE Complex Assembly. J Biol Chem, 277, 28271-9.
Schafer, D.A. (2002) Coupling actin dynamics and membrane dynamics during endocytosis. Curr 
Opin Cell Biol, 14,76-81.
Schmidt, A. and Hall, M.N. (1998) Signaling to the actin cytoskeleton. Annu Rev Cell Dev Biol, 14, 
305-38.
113
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Sekino, Y., Obata, K., Tanifuji, M., Mizuno, M. and Murayama, J. (1997) Delayed signal propagation 
via CA2 in rat hippocampal slices revealed by optical recording. J Neurophysiol, 78,1662-8.
Shima, F., Yamawaki-Kataoka, Y., Yanagihara, C., Tamada, M., Okada, T., Kariya, K. and Kataoka, 
T. (1997) Effect of association with adenylyl cyclase-associated protein on the interaction of yeast 
adenylyl cyclase with Ras protein. Mol Cell Biol, 17,1057-64.
Shin, O.H., Rizo, J. and Sudhof, T.C. (2002) Synaptotagmin function in dense core vesicle 
exocytosis studied in cracked PC12 cells. NatNeurosci, 5,649-56.
Shupliakov, 0., Bloom, 0., Gustafsson, J.S., Kjaerulff, 0., Low, P., Tomilin, N., Pieribone, V.A., 
Greengard, P. and Brodin, L. (2002) Impaired recycling of synaptic vesicles after acute perturbation 
of the presynaptic actin cytoskeleton. Proc Natl Acad Sci USA,  15,15.
Smart, F.M. and Halpain, S. (2000) Regulation of dendritic spine stability. Hippocampus, 10, 542-54.
Sollner, T., Whitehead, S.W., Brunner, M., Erdjument-Bromage, H., Geromanos, S., Tempst, P. and 
Rothman, J.E. (1993) SNAP receptors implicated in vesicle targeting and fusion. Nature, 362,318- 
24.
Sudhof, T.C. (1995) The synaptic vesicle cycle: a cascade of protein-protein interactions. Nature, 
375, 645-53.
Sudhof, T.C. (2002) Synaptotagmins: why so many? J Biol Chem, 277, 7629-32.
Sugita, S., Han, W., Butz, S., Liu, X., Fernandez-Chacon, R., Lao, Y. and Sudhof, T.C. (2001) 
Synaptotagmin VII as a plasma membrane Ca(2+) sensor in exocytosis. Neuron, 30,459-73.
Sugita, S., Ho, A. and Sudhof, T.C. (2002) NECABs: a family of neuronal Ca(2+)-binding proteins 
with an unusual domain structure and a restricted expression pattern. Neuroscience, 112,51-63.
Sugita, S. and Sudhof, T.C. (2000) Specificity of Ca2-Hlependent protein interactions mediated by 
the C2A domains of synaptotagmins. Biochemistry, 39,2940-9.
Swiston, J., Hubberstey, A., Yu, G. and Young, D. (1995) Differential expression of CAP and CAP2 
in adult rat tissues. Gene, 165, 273-7.
Teng, F.Y., Wang, Y. and Tang, B.L. (2001) The syntaxins. Genome Biol, 2, REVIEWS3012. 
Thomas, D.M., Ferguson, G.D., Herschman, H.R. and Elferink, L.A. (1999) Functional and 
biochemical analysis of the C2 domains of synaptotagmin IV. Mol Biol Cell, 10, 2285-95.
Trifaro, J., Rose, S.D., Lejen, T. and Elzagallaai, A. (2000) Two pathways control chromaffin cell 
cortical F-actin dynamics during exocytosis. Biochimie, 82,339-52.
Urrutia, R., Henley, J.R., Cook, T. and McNiven, M.A. (1997) The dynamins: redundant or distinct
114
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
functions for an expanding family of related GTPases? Proc Natl Acad Sci USA,  94,377-84.
Vojtek, A., Haarer, B., Field, J., Gerst, J., Pollard, T.D., Brown, S. and Wigler, M. (1991) Evidence 
for a functional link between profilin and CAP in the yeast S. cerevisiae. Cell, 66,497-505.
Vojtek, A.B. and Cooper, J.A. (1993) Identification and characterization of a cDNA encoding mouse 
CAP: a homolog of the yeast adenylyl cyclase associated protein. J Cell Sci, 105,777-85.
Warren, D.T., Andrews, P.D., Gourlay, C.W. and Ayscough, K.R. (2002) S lalp couples the yeast 
endocytic machinery to proteins regulating actin dynamics. J Cell Sci, 115,1703-15.
Welch, M.D. and Mullins, R.D. (2002) Cellular Control of Actin Nucleation. Annu Rev Cell Dev Biol, 
10, 10.
Wesp, A., Hicke, L., Palecek, J., Lombardi, R., Aust, T., Munn, A.L. and Riezman, H. (1997) 
End4p/Sla2p interacts with actin-associated proteins for endocytosis in Saccharomyces cerevisiae. 
Mol Biol Cell, 8,2291-306.
Wills, Z., Emerson, M., Rusch, J., Bikoff, J., Baum, B., Perrimon, N. and Van Vactor, D. (2002) A 
Drosophila homolog of cyclase-associated proteins collaborates with the abl tyrosine kinase to 
control midline axon pathfinding. Neuron, 36,611-22.
Yu, G., Swiston, J. and Young, D. (1994) Comparison of human CAP and CAP2, homologs of the 
yeast adenylyl cyclase-associated proteins. J Cell Sci, 107,1671-8.
Yuste, R. and Bonhoeffer, T. (2001) Morphological changes in dendritic spines associated with 
long-term synaptic plasticity. Annu Rev Neurosci, 24,1071-89.
Yuste, R., Majewska, A. and Holthoff, K. (2000) From form to function: calcium 
compartmentalization in dendritic spines. Nat Neurosci, 3,653-9.
Zeidman, R., Trailer, U., Raghunath, A., Pahlman, S. and Larsson, C. (2002) Protein kinase 
Cepsilon actin-binding site is important for neurite outgrowth during neuronal differentiation. Mol Biol 
Cell, 13,12-24.
Zelicof, A., Gatica, J. and Gerst, J.E. (1993) Molecular cloning and characterization of a rat homolog 
of CAP, the adenylyl cyclase-associated protein from Saccharomyces cerevisiae. J Biol Chem, 268, 
13448-53.
Zelicof, A., Protopopov, V., David, D,, Lin, X.Y., Lustgarten, V. and Gerst, J.E. (1996) Two separate 
functions are encoded by the carboxyl-terminal domains of the yeast cyclase-associated protein 
and its mammalian homologs. Dimerization and actin binding. J Biol Chem, 271,18243-52.
Zhang, W. and Benson, D.L. (2001) Stages of synapse development defined by dependence on F- 
actin. J Neurosci, 21,5169-81.
115
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
A P P E N D IX  A
Table 2. Primers used for amplification of PCR products.
# Primer Name Sequence 5' - 3'
3 1 L E X C A P 2 - F T T  G A A T T  C A T  G G C C  A A C A T  G C  A G G G A C T  G G
3 2 L E X C A P 2 - R T T  C T  C G A G T T A G G C C A T A A T T T  C T  G C  A G G
5 2 G A P D H - F T  C  A A T G G A A A T  C C C  A T  C  A C C  A T
5 3 G A P D H - R C T C C T T G G  A G G C C A T  G T G G G C C
9 3 C IP 1 S E Q 1 - F A G A A T T C C C T  G G  A A T  G T  G C C
9 7 H C IP 5 A - F T T C T  C G A G A T  G G A A G  A T T  C C C A G G A G A C  A T  C G
9 9 H C IP - R T T C T C  G  A G C T A G T T  G T T C  A G G  A T C C  A C C  A C  G  A
1 0 8 H A C A P 2 C 2 3 2 - F T T  G A A T T  C C T T T T  C G  A G A A T  G A A G C  A A A A A A A G
1 0 9 H A C A P 2 N 3 0 4 - R T T  C T  C G A G T T A G G T  G G G A G A T T  G A G T T T  G C C C
1 2 3 G S T C A P 2 - F T T  G A A T T C G G A T  G G C C A A C A T  G C A G G G A C T  G
1 2 4 V P S T I P B A M - F T T  G G A T  C C C C A T  G G  A A G A T T  C C C  A G G  A G  A C  A
1 2 5 V P S T I P N O T - F T T  G C G G C C G C T A A T  G G  A A G A T T  C C C A G G A G A C
1 2 7 V P N 2 8 4 - R T T  G C G G C C G C T  A T C C A C T T T  G G G A G G A A G C A C
1 2 8 V P N 2 5 0 - R T T  G C G G C C G C T A G T  G A G A T T T A G T A T T  C C C T
1 2 9 V P N 2 0 0 R T T  G C G G C C G C T A A A A C T  G  A G G G C T  G T T T  G G
1 3 0 V P S T I P - R T T  G C G G C C G C T A G T T  G T T C A G G A T C C A C C A C G
1 3 6 V P C 1 5 6 - F T T  G C G G C C G C C A A A C A G C C C T  C  A G T T T A A T  G
1 3 7 L E X S T IP - F T T  C T  C G A G T T A T  G G A A G A T T C C C A G G A G A C
1 3 8 V P C 1 0 0 - F T T  G C G G C C G C A C A T C A T  G C T T  G T  G C A G C G G
1 4 2 V P C 2 2 6 N 0 T - F T T  G C G G C C G C  A C T T  G G G C G A G T A T  G  A G A A T  G
1 5 3 I L 2 2 8 2 3 1 K R - F A A C C  A G T  G G A T  G  A C C C A G A A A A A T A G  A C G C C  A G A A A T T A A T T  G A T
1 5 4 IL 2 2 8 2 3 1 K R - R A T  C A A T T A A T T T  C T  G G C G T  C T A T T T T T C T  G G G T  C A T  C C  A C T  G G T T
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